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CHAPTER 1 
 
INTRODUCTION 
 
1. Background 
A wide range of chemical species ranging from small molecules to peptides are 
known to function as neurotransmitters and play a role in a variety of biological 
conditions ranging from cognition and arousal to disease and addiction [1].  While the 
synaptic gap between neurons is smaller (~20 nm) than current probes, neurotransmitters 
not bound to receptors, reuptaken or degraded diffuse into the much larger extracellular 
matrix of the brain.  Dynamics in these neurotransmitters in live animals in response to 
external stimulus are usually measured by sampling the extracellular matrix with some 
changes in the subsecond regime.  While several of these species are widely studied, 
neuropeptides are more difficult to study because of their low concentration (<100 pM) 
and lack of electrochemical sensors to detect them [1-4].  The neuropeptides neurotensin, 
the enkephalins, and beta-endorphin have been implicated in a variety of behaviors and 
diseases including feeding, pain, drug abuse, Parkinson’s and schizophrenia [5-7]; 
moreover, current techniques are limited to quantifying these peptides at a temporal 
resolution of ~30 minutes [8]. 
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Figure 1.1. Neurotransmission across a synapse (~600 nm) via chemical transmitters released by an action 
potential from the pre-synaptic neuron is depicted in the scheme.  Chemical neurotransmitters (red) are 
either uptaken by the pre- or post-synaptic neuron via transporters (purple), enzymatically degraded (green) 
or diffuse into the extracellular space (dashed arrow). 
 
Quantitative analytical methods for measuring the dynamics of neuropeptides 
include microelectrodes and imaging techniques such as positron emission tomography.  
These techniques allow high temporal resolution and noninvasiveness, respectively, but 
with a limited range of analytes and insufficient spatial resolution for rodent studies, 
respectively [3, 4, 9].  Microdialysis sampling, where analytes diffuse across a hollow 
fiber membrane into a perfusing stream and are convectively transported to the detection 
system, allows quantification and is easily coupled to traditional analytical techniques 
such as LC-MS, HPLC and radioimmunoassay [3, 10, 11]; however, a major limitation of 
this method is the large sample requirements for these detection techniques. 
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2. Microfluidic Devices 
 Rapid advances in fabrication technology in the semiconductor industry has 
resulted in both the ubiquity of digital electronic devices throughout our lives and results 
in a logarithmic decrease in scale of features fabricated [12].  The application of this 
technology to the miniaturization of chemical instrumentation is known as microfluidics 
[13].  As discussed in numerous reviews, microfluidics offers several advantages over 
conventional analysis including, but not limited to, rapid mixing, small sample and 
reagent use, portability, reduction in analysis cost, and unique phenomena due to the 
physical forces that dominate at scales near 1 micron [14-19].  While a microfluidic 
platform was chosen due to its compatibility with the small sample volumes resultant 
from microdialysis sampling, microfabrication also allows for the integration of several 
of these advantages into our analytical device.  Specifically, the device described herein 
utilizes the small scale for rapid mixing of reagents and the fluid flow is then segmented 
into water-in-oil droplets to preserve temporal resolution by preventing dispersion as the 
sample travels to analysis [19]. 
 
3. Fluorescence Polarization Immunoassay 
Immunoassays are ubiquitous in biochemical analysis.  In a competitive 
immunoassay, the antigen of interest competes with labeled antigen for antibody binding 
sites such that the quantity of an analyte is a function of the ratio of bound to unbound 
labeled antigen [20].  Since a fluorophore will only absorb if its dipole is aligned with the 
electric field of the light, fluorescence is polarization dependant; specifically, if a 
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population of fluorophore is excited with polarized light, the polarization of emitted light 
is determined by the amount of rotation the species undergoes.  If this population of 
excited molecules rotates much more rapidly than the fluorescence lifetime, then the 
fluorescence will be isotropic; conversely, if the fluorophore is bound to another species, 
then its rotation will be encumbered and the fluorescence anisotropy will be larger [20, 
21].   While this method of analysis is limited to analyzing a single species, advantages 
include the commercial availability of antibodies to bind a wide range of analytes and the 
modularity of the system. 
While fluorescence anisotropy immunoassays have been previously demonstrated 
both in our lab and commercially, this technique has not been previously coupled to 
microfluidics.  Several groups have demonstrated advantages to using segmented flow in 
microfluidic devices including limiting diffusion, chaotic mixing, and confined nL 
volumes [19].  The combination of an immunoassay and segmented flow microfluidics 
allows high mass sensitivity and throughput with automation and low sample 
requirements. 
 
4. On-chip Preconcentration 
 Several methods for concentrating peptides on microfluidic devices have been 
demonstrated [22, 23], including solid phase extraction [24], liquid-liquid extraction [25-
29], and electrokinetic stacking or trapping [24, 30-33].  Of reported techniques, only 
electrokinetic trapping at micro-nano-fluidic junctions can repeatedly enrich samples by 
factors at and greater than 106 on a timescale of minutes [34].  Where nanofluidic 
structures are technically difficult to integrate into microfluidic devices due to a greater 
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than 104 difference in feature size, a similar enrichment phenomena has been reported by 
using floating electrodes patterned in a microchannel, known as a bipolar electrode [35].  
In this work, we broaden the application of this bipolar electrode to be compatible with 
highly ionic media such as is found in neurotransmitter sampling.  While the Han group 
has reported an integrated preconcentrator and droplet generator to reduce dilution by 
dispersion [36], the continuous generation of droplets at volumes smaller than the 
concentrated band diluted the analytes by splitting them between droplets; moreover, the 
large droplet storage reservoir mixed the water-in-oil droplets such that all temporal 
resolution was lost. 
 
5. Finite Element Method Modeling 
 While direct analytical measurements are preferable, several physical and 
chemical parameters are not measureable at the scale of microfluidic devices.  Where 
direct numerical solutions of the equations governing pressure-driven flow, electrokinetic 
flow, and mass transport cannot be directly solved, a variety of commercially available 
software suites allow the approximation of these equations as solvable ordinary 
differential equations and the discretization of these systems into grids with units 
sequentially solved until the error between boundaries reaches an acceptably low level 
[37, 38].  In this work, electrokinetic and pressure driven flow were governed by the 
following equations (assuming continuity): 
 ρ(∂V/∂t + (V•∇)V) =  -∇p + µ∇2V + εκ2ψ∇φ  
where the electric field was decoupled into the external field and electrostatic field 
resultant from the charged walls: 
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 Φ = φ + ψ  
Potentials were considered to be zero when no external potential was applied to the 
system.  Similarly, convection and diffusion were calculated by solving Fick’s Law of 
Diffusion (at constant temperature): 
∂c/∂t + (V•∇)C = D∇2C 
where diffusion coefficients were approximated as their corresponding literature reported 
values. 
 
6. Dissertation Overview 
The overall goal of this dissertation is to create an integrated microfluidic device 
that preconcentrates continuous in vivo microdialysate sampling from rodent central 
nervous system and quantify neuropeptides therein with a fluorescent immunoassay.  
While microdialysis is commonly used in sampling neurotransmitter release, the 
components of the microfluidic device were individually designed and tested in model 
systems. 
First, a fluorescence anisotropy competitive immunoassay for insulin secretion 
from Islets of Langerhans was developed and modified for compatibility with the 
segmented flow system to preserve temporal resolution.  This assay was then used in a 
microfluidic device with both integrated Islet culture and chemical gradient delivery.  
This device was able to measure insulin secretions in a non-destructive manner from 
Islets stimulated by glucose. 
Next, a bipolar electrode preconcentrator was developed to function with the 
highly conductive media used in neurotransmitter sampling.  The device was optimized 
	   7	  
in scale for the bulk flow and low abundance of neuropeptides expected in microdialysis 
sampling.  To prevent bubble formation prevalent under the high potentials applied in this 
technique, a novel method of using evacuated PDMS was employed.  In a model for 
neuropeptide preconcentration, labeled proteins were stacked into bands and sequestered 
into water-in-oil droplets for analysis downstream. 
Finally, several microfluidic systems were analyzed by finite element method 
modeling to determine both ideal performance limits and non-analytically measurable 
properties (e.g. shear stress and diffusion of species that could not be imaged) of the 
devices.  A microdialysis sample probe was modeled as segments in three-dimensions to 
determine the effects of perfusion flow rate and geometry on sample recovery; these 
results were compared to experimental results.  Both the Islet of Langerhans perfusion 
chamber, used in a variety of microfluidic devices, and an adipocyte cell culture were 
modeled to analyze both geometric and flow rate effects on gradient delivery and shear 
rate.  The FPIA device was modeled to determine the effective performance of the device 
in rapidly changing chemical gradients, mixing of reagents, and the retention of temporal 
resolution; additionally; biochemical secretions from individual Islet of Langerhans were 
modeled. 
 This dissertation describes a non-destructive quantitative measurement technique 
widely applicable to any small biomolecule with an antibody, a preconcentration system 
to enrich trace neuropeptides to quantifiable concentrations, and the numerical modeling 
of these devices.  These devices illustrate that a droplet-based FPIA is a versatile 
analytical technique for application in miniaturized chemical and biochemical 
instrumentation.  
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CHATPER 2 
 
QUANTITATIVE FLUORESCENCE POLARIZATION IMMUNOASSAY 
ANALYSIS OF PEPTIDE SECRETIONS IN MICROFLUIDIC DEVICES 
 
1. Introduction 
Segmented flow, in which aqueous samples are partitioned within a carrier 
phase of immiscible fluid, has emerged as powerful way to manipulate low 
volume samples (10 nL and less) in microfluidic analytical systems.  This 
approach, which may also be considered a miniaturization of “segmented flow 
analysis [1, 2]”, creates several advantages for analytical measurement including 
high surface area per unit volume [3], high throughput [4], multiplexed analysis 
[5], discrete sample storage [6, 7], and mitigation of dispersion in temporal 
sampling [8, 9].  These multiphase systems commonly consist of water-in-oil 
droplets produced in microfluidic devices as a result of hydrodynamic focusing 
[10] or shear-induced droplet breakup at a geometry such as a T-junction [11, 12]. 
Analytes sequestered in water-in-oil droplets have previously been 
analyzed by a variety of methods including: off-line analysis by fluorescence 
microscopy [13], off-line and on-line mass spectrometry [14-17], electrophoresis 
[18, 19], fluorogenic enzyme assay [8], and FRET assay [4].  Fluorescence 
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polarization immunoassay (FPIA) is a homogenous immunoassay method that is 
well-suited for analysis of low volume plugs in multi-phase systems because of 
the relatively simple requirements for reagent addition and optical readout.  
Furthermore, this method can complement enzymatic and FRET methods by 
providing a route for detecting nearly any small molecule that can have an 
antibody or aptamer raised against it.  Indeed, commercially available macroscale 
FPIA kits and systems are routinely used for quantifying drugs and hormones 
(e.g. the Abbott TDx system).  Further, fluorescence polarization is a highly 
valuable method for high-throughput screening.  
 The principle of a FPIA is illustrated in Figure 2.1.  Fluorophores excited 
with polarized light will emit fluorescence with higher anisotropy as molecular 
volume increases due to decreasing molecular rotation [20].  In FPIA, a labeled 
antigen and antibody are added to a sample.  In the absence of unlabeled antigen 
(analyte), most of the labeled antigen is bound to antibody resulting in high 
anisotropy.  As analyte concentration increases, the labeled antigen is displaced 
and anisotropy decreases [21].  
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Figure 2.1. Scheme of competitive heterogeneous fluorescence polarization immunoassay in the 
presence of low (top) and high (bottom) antigen concentrations.  Fluorescent-labeled antigens 
compete with unlabeled antigen from a sample matrix for binding sites on antibodies lowering the 
ensemble rotation of the fluorophores in an inverse relationship to antigen concentration from the 
sample. 
 
In this work, we demonstrate FPIA in droplets using on-line addition of 
reagents to a sample stream.  The system is applied to measurement of insulin 
release from single Islets of Langerhans perfused in culture on a microfluidic 
chip.  Islets are micro-organs within the pancreas that contain several types of 
endocrine cells including insulin producing β-cells [22].  Interest in Islet secretory 
function is driven by the relationship between declines in insulin release and 
development of type-2 diabetes.  Methods for monitoring insulin secretion are 
valuable for determining kinetics of insulin secretion during physiological 
manipulation of Islets and possibly for evaluating Islets to be used for Islet 
transplant.   
Traditional methods of insulin quantification are radioimmunoassay and 
ELISA.  These methods typically have slow feedback and are expensive to use if 
high temporal resolution is required because of the many samples that must 
analyzed.  Our group has developed electrophoretic immunoassay schemes that 
have good temporal resolution at low cost per assay [23]. Fluorescence correlation 
spectroscopy in a plug format [5] has also recently been used to monitor insulin 
secretion from single Islets.  We demonstrate that FPIA in droplets has the 
potential to be a simple method for monitoring insulin release with high temporal 
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resolution.  The use of segmented flow allows maintenance of high temporal 
resolution for the measurement.   
 
2. Experimental 
2.1 Chemicals and Reagents 
KCl, MgCl2, CaCl2, HF, HNO3, H2SO4, H2O2, NH4OH, EDTA, NaCl, 
HCl, NaOH and methanol were obtained at the highest quality from Fisher 
Scientific.  Insulin labeled with fluorescein isothiocyanate (FTC-insulin) and 
insulin antibody used in the immunoassay were purchased from Invitrogen and 
Biodesign International, respectively.  Tricine, electrophoresis grade albumin 
from bovine serum (BSA), insulin from bovine pancreas (insulin), 
trichloro(1H,1H,2H,2H-perfluorooctyl)silane (FTS), anhydrous hexanes, 
anhydrous chloroform, fluorescein, perfluorodecalin (oil) and molecular sieve, 2A 
were all purchased at the highest purity from Sigma. 
 
2.2 Solutions and Buffers 
All aqueous solutions were prepared with 18 M-Ohm water (Millipore, 
Bedford, MA), were pH balanced with addition of 1 M NaOH, and were filtered 
with a 0.40 um filter.  Immunoreagent buffer (IMR) consisted of 50 mM NaCl, 1 
mM EDTA and 20 mM tricine, while balanced salt solution (BSS) was comprised 
of 125 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 2.4 mM CaCl2, 25 mM tricine.  
Both solutions were adjusted to pH 7.4 with dropwise addition of 1 M NaOH and 
0.7 mg/mL of bovine serum albumin (BSA) was added. 
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2.3 Microfluidic Device Fabrication 
An emulsion plot from a computer aided drafting design was printed at 
50400 dpi resolution (Fineline Imaging, Colorado Springs, CO).  This master 
design was transferred to 1.1 mm thick Borofloat® glass substrates (Telic 
Company, Valencia, CA) coated with 120 nm chromium and 530 nm AZ1518 
photoresist (Clariant, Summerville, NJ), respectively, by exposing the substrate to 
2 s of UV light (26 mW/cm2) while spatially filtered by the emulsion plot and 
removal of exposed photoresist and chrome with AZ915 MIF developer (Clariant, 
Summerville, NJ) and CEP-200 chrome etchant (Microchrome Technologies, San 
Jose, CA), respectively.  80 µm deep channels were wet chemically etched in 
48/17/35% HF/HNO3/H2O and verified with a Dektak 4 profilometer (Veeco 
Instruments Inc., Plainview, NY).  Access holes to channels were drilled with 300 
µm diameter diamond tipped drill bits (KYOCERA America, Inc., San Diego, 
CA) on a 10" drill press and substrates were bonded to Borofloat® 1.1 mm thick 
coverslides after sonication and cleaning in 2:1 H2SO4/H2O2 (v/v) for 10 minutes 
and 5:1:1 H2O/NH4OH/H2O2 (v/v) for 20 minutes prior to bonding substrates to 
coverslides between MACOR ceramic plates (Astro Met, Cincinnati, OH) in a 
glass kiln for 6 hours at 610 °C. 
Connections to the device were made with Nanoport reservoirs (IDEX® 
Health & Science, Oak Harbor, WA) and 75/360 µm i.d./o.d. fused silica 
capillary.  Capillaries used for droplet detection (outlet capillaries from the 
devices) were 55 cm in length with the polyimide coating burned from a 2 mm 
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window 50 cm from the end of the capillary that was carefully aligned to fit in the 
outlet access hole. 
 
2.4 Surface Modification 
All channels of devices were modified by silation chemistry [24].  Unless 
otherwise stated all solutions were pumped at 20 µL/min for 30 minutes.  Channel 
and capillary walls were cleaned with 500 mM NaOH, rinsed with 18 MΩ water, 
activated with 1 M HCl and dried with methanol.  While priming the device with 
anhydrous hexane, a 5 mM solution of FTS in 3:1 (v/v) hexane/chloroform was 
prepared.  This silation solution was pumped at 10 µL/min for an hour before 
rinsing with anhydrous hexane and drying with methanol.  Outlet capillaries, 
which transport droplets off-chip, were modified in a similar manner.  
Hydrophobic regions were removed from the perfusion channel, Islet chamber 
and reagent channels by pumping 500 mM NaOH through these channels while 
pumping methanol through the oil and droplet channel/capillaries.  All devices 
were dried with methanol and stored in a desiccator prior to use. 
 
 
2.5 Droplet Generation and Device Operation 
For experiments, the device was mounted over a resistive heater strip that 
covered the cell chamber.  Voltage was applied to the strip to maintain a 
temperature of 37 oC in the cell chamber.  Fluid flow in the device was driven by 
CMA/102 (CMA Microdialysis, Sweeden) and PHD 2000 (Harvard Apparatus, 
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Holliston, MA) syringe pumps fitted with gas-tight syringes (Hamilton, Reno, 
NV).     Flow through the perfusion inlets was driven at a total of 1 mL/min.  
Perfluordecalin was pumped at 1-2 mL/min.  The oil flow rate was adjusted to 
generate plugs at 3-5 Hz.  Chemical gradients in perfusion media over time were 
generated on-chip by variation of flow rates for perfusion inlet channels while 
maintaining a constant total perfusion flow rate of 1 µL/min.  Switching of pump 
rates was controlled remotely by serial cable with in-house written software. 
 
2.6 Fluorescence Anisotropy Detection 
Plugs generated on-chip were pumped on-line into a capillary that was 
mounted in a fluorescence anisotropy detector similar to that described elsewhere 
[25-27]. Briefly, fluorescence was excited in the plugs within the capillary as they 
flowed through a focused 488 nm laser beam (Sapphire 488 30 CDRH, Coherent, 
Santa Clara, CA).  The detection point was 50 cm downstream of the microfluidic 
chip.  Parallel and perpendicular polarized fluorescence signal was collected at 
100 Hz by in-house written LabView 8.5 virtual instrument (National 
Instruments, Austin, TX) with SR570 low noise current preamplifiers (Stanford 
Research Systems, Sunnyvale, CA).  Signals were adjusted for baseline and 
differences in detector sensitivity (i.e., the G-factor) [20].  Droplet data points 
were parsed from trace for each channel and anisotropy (r) calculated by the 
equation:  
€ 
r = Iparallel −G × IperpendicularIparallel + 2 ×G × Iperpendicular
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Anisotropy values were averaged for every droplet and were plotted as a function 
of time.  For each experiment, parallel and perpendicular signals for fluorescein 
were measured and use to solve for the G-factor to match the literature anisotropy 
(r) value. 
 The fluorescence polarization immunoassay was optimized using a Fusion 
microplate reader (PerkinElmer, Waltham, MA).  Insulin in BSS solution was 
mixed with half volume equivalents of FTC-insulin and antibody in IMR solution 
in microcentrifuge tubes and then transferred to a 384-well microplate for 
measurement assuming a 60 s incubation time.   
 
2.7 Numerical Modeling of Sampling Single Islets with Perfusion 
The performance of the perfusion chamber was numerically modeled in 
three dimensions using commercial finite element software, COMSOL 3.3 
(COMSOL, Inc., Burlington, MA).  Channel shapes were approximated as 
parallelogram with a height of 80 µm and top and bottom widths of 160 and 80 
µm, the perfusion chamber was approximated as a 1100 µm tall cylinder with 360 
µm diameter, and the Islet was approximated as a 150 µm sphere centered 70 µm 
from the bottom of the chamber.  Viscosity and density of water were assumed to 
be 6.90 × 10−4 Pa s and 993 kg m-3, respectively.  The diffusion coefficient at 37 
°C was 7.30 × 10−10 m2 s-1 [28]. 
In all models, boundaries of inlets were defined with laminar flow profiles 
and fluid dynamics were solved at steady state conditions first.  These solutions 
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were then used as parameters to solve convection and diffusion over a course of 1 
min with 0.01 s time steps.  The effect of the perfusion chamber on temporal 
resolution was modeled by defining the concentration at the inlet boundary of the 
mixing channel, located 500 µm upstream of the perfusion chamber, as a step 
change 1 s after the model began.  Step changes were defined as a Heaviside 
function with smoothed first derivative.  Islet sampling performance was modeled 
by integrating concentration across the outlet boundary as a function of time after 
a step change in concentration on the Islet surface. 
 
2.8 Switching and Mixing Performance 
On-chip mixing and the temporal response of the device were analyzed by 
imaging gradients in time of fluorescent dye at various points on the device.  BSS 
and 100 nM fluorescein in BSS were pumped at a combined flow rate of 500 
nL/min in the respective perfusion inlets, IMR was pumped in both 
immunoreagent inlets at 250 nL/min, and perfluorodecalin was pumped in the oil 
inlet at 1000-2000 nL/min.  Mixing was monitored by line-scan analysis of 
images collected at the beginning of the mixing channel, end of the mixing 
channel and just prior to droplet formation using Igor Pro 6.0.3.1 (WaveMetrics, 
Inc., Lake Oswego, OR).  Similarly, the temporal response to changes in pumping 
flow rate was determined by collecting time lapse images at the three regions of 
interest in the mixing experiment at 1 Hz and plotting the sum of the intensity of 
the 5 points centered around the maximum for each line-scan at the end of the 
mixing channel and immediately prior to droplet formation.  Temporal responses 
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to these gradient changes in the capillary were compared between segmented and 
continuous flow, where perfluorodecalin in the oil channel was replaced with 
IMR, by parsing parallel fluorescent signal from droplets and plotting respective 
of time point data.  All experiments were performed in triplicate. 
 
2.9 Fluorescence Anisotropy Immunoassay Calibration 
Prior to measuring insulin released from Islets, devices were calibrated by 
pumping insulin standards at 500 nL/min, 60 nM FTC-insulin at 250 nL/min and 
30 nM antibody at 250 nL/min into the perfusion inlets of the device (see Figure 
2.2).  Oil was pumped at 1500 nL/min to generate plugs that were the passed into 
the detector.   Signal from 50 droplets for each concentration were averaged for 
the calibration.  Fluorescence anisotropy as a function of insulin concentration 
was fit as a one-site, total binding curve in Prism 5 (GraphPad Software, Inc., La 
Jolla, CA) for quantification. 
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Figure 2.2. Scheme of Islet perfusion glass microchip (a) with 80 µm deep and 120 µm half width 
channels:  droplets are formed at the interface of the aqueous (black) and oil (grey) phases and 
transported through hydrophobically modified channels and capillary to a laser induced 
fluorescence photodetection system.  All flow was driven by external syringe pumps as depicted.  
An image of the device inverted to display channels with a cent piece for reference (b) and a 
cartoon of the FPIA for low and high insulin concentrations (c) are shown. 
 
2.10 Biological Samples and Glucose Stimulated Insulin Release 
Islets were isolated from male CD-1 mice as previously described [23].  
 22 
Isolated Islets were incubated in RPMI 16440 media with 10% fetal bovine 
serum, 100 UI/mL penicillin and 100 µg/mL streptomyin for 2-5 days in an 
incubator maintained at 5% CO2 and 37 oC before experimentation.  For on-chip 
experiments single Islets with healthy membranes and diameters of ~150 µm were 
transferred to a cell culture dish with 37 oC BSS with 3 mM glucose added.  The 
single Islet was then gently transferred to the Islet perfusion chamber via pipette 
and observed to settle on the bottom of the chamber as viewed under a 
stereoscope.  After sealing the Islet perfusion chamber, BSS with 3 mM glucose 
was perfused through the Islet chamber and the plug generation was re-
equilibrated.   
 
3. Results and Discussion 
3.1 Fluorescence Polarization Immunoassay Calibration and Figures of Merit 
Initial experiments were directed to developing a FPIA in multiphase flow 
using the chip shown in Figure 2.2.  In this system, a stream of insulin standard or 
Islet superfusate merges with streams of FTC-insulin and antibody before 
reaching a T-structure where aqueous plugs are formed within a carrier of oil.  At 
plug formation rapid mixing of the reagents and sample occurs due to chaotic 
mixing [6] as previously modeled [29] and observed [6, 30].  Samples are then 
transported off the chip and through a capillary tube where they are detected in 
capillary using a laser-induced fluorescence polarization detector [25-27].  
Parallel and perpendicular oriented fluorescence components are detected on each 
droplet as shown in Figure 2.3A.  These signals are then converted to anisotropy 
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as described in the Experimental section.  Increasing the concentration of insulin 
in the sample stream results in decreases in anisotropy as expected (see Figures 
2.1 and 2.3).  Flowing different concentrations through the sample channel allows 
calibration of the assay as shown in Figure 2.3.  The sigmoidal curve response 
was similar to other competitive immunoassays and previously reported 
electrophoretic immunoassays using this antibody and FTC-insulin combination 
[23, 31-35].   
 
Figure 2.3. FPIA in droplet response as a function of insulin concentration with a representative 
calibration curve of average anisotropy from 50 droplets at various insulin concentrations with G-
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factor calculated from fluorescein standards (a).  Parallel (black) and perpendicular (grey) signal 
from plugs in capillary with calculated anisotropy (black bars) at high (1000 nM) and low (10 nM) 
insulin concentrations are shown in (b) and (c), respectively. 
 
Several factors including antibody-antigen affinity, labeled-antigen 
fluorescent intensity and reagent concentrations determine both the limit of 
detection and dynamic range of a FPIA.  Although antibody-antigen affinity (Ka ~ 
1×109 M-1) and fluorescent intensity are fixed for a given experiment, antigen 
(insulin) and immunoreagent concentrations are a function of the relative flow 
rates used in the perfusion system.  These flow rates must be set to balance 
several competing performance requirements.  Sample flow rate must be 
sufficient to rapidly wash out the Islet chamber to ensure both good temporal 
resolution of monitoring and adequate media flux for cell health; however, if the 
flow rate is too high it will overly dilute released insulin and could cause shear 
stress on the Islet.  Additionally, the range of flow rates for sample and reagent 
stream and carrier fluid is constrained to regimes where droplets are reproducibly 
produced with sufficiently high frequency to monitor the sample and reagent 
stream with good temporal resolution.    The flow rate also affects the 
concentration of reagents, which in turn influences the sensitivity range of the 
FPIA.   
Using previous work for plug formation [8, 18], insulin competitive 
immunoassay [23, 31-33], and Islet release as a guide we identified the following 
conditions as appropriate for the monitoring insulin secretion using the FPIA: 
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sample flow rate = 500 nL/min, reagent flow rate = 500 nL/min (combined from 
equal 60 nM FTC-insulin and 30 nM antibody flow rates), and oil carrier fluid 
flow rate = 1000 nL/min.  Using these conditions, detection limits as low as 6 nM 
were achieved for insulin in droplet detection.  Anisotropy scaled negatively with 
the logarithm of insulin concentration into the µM range (see Figure 2.3).  This 
concentration range correlates to a range of insulin secretion of ~15 to 3000 
pg/min of insulin, which is within the expected range for insulin release from 
single Islets [36-38].  While these conditions are insufficient to measure basal 
insulin secretions in many experiments, recalibration at a lower flow rate lowers 
the detection limit and dynamic range; for example, the presence of insulin 
secretions below the detection limit was confirmed in each experiment by 
decreasing the perfusion flow rate to 250 nL/min and both immunoreagent flow 
rates to 125 nL/min before glucose stimulation.  Improvements to the microfluidic 
device such as Islet chamber dead-volume, would allow more sensitive insulin 
measurements.  Anisotropy signals for 5 nM insulin had relative standard 
deviations of 2.1 to 8.3% on a single chip and 13 to 19% between chips when 
binning signals across 2 s periods.  
In the course of experiments we observed more variability in plug size, as 
apparent in the traces in Figure 2.3B and 2.3C, than expected.  This variability 
was partially attributable to unexpected roughness in the surface of wet-etched 
channel walls.  (This rough etching was eventually found to be due to poor quality 
in the lot of glass slides used for this work and is not expected to be a problem in 
future work.)  A second contributor to irregular droplets was that during transfer 
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from the glass chip to through the irregular geometry of the drilled outlet hole-
nanoport assembly minor droplet break-up and coalescence could occur.  (Later 
work has demonstrated methods for avoiding these effects [39].)  Polydispersity 
in droplets did not affect quantification as anisotropy was calculated for each 
droplet and droplets were binned.  Further, droplets were created at higher 
frequency than the expected temporal changes in insulin. 
 
3.2.1 Temporal Resolution  
Using segmented flow allows creation of discrete samples with fixed 
concentrations of reagent that, except for the coalescence mentioned above, 
cannot mix with each other.  For the application of monitoring cellular function 
this feature of segmented flow is advantageous in preserving temporal resolution 
of concentration changes even though the sample must be transported a 
significant distance to a detector and a sufficient incubation time is necessary for 
the assay.  For Islet secretion measurements, temporal resolution is an important 
feature because insulin secretion is known to have rich dynamics including 
oscillations with a period of 2-5 min and possibly faster spikes with periods of 10 
s [40-42].     
 
3.2.2 Temporal Resolution (Numerical) 
It was of interest to determine the temporal distortion of insulin secretion 
measured downstream.  Unfortunately, it was experimentally difficult to make 
step changes of concentration within the Islet chamber, therefore the temporal 
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response achievable for sampling secretions from an Islet was determined by 
numerically modeling the three-dimensional geometry of the channels on the chip 
(see Figure 2.4A).  Simulations showed that an instantaneous pulse of insulin 
released from the Islet surface was rapidly washed away from the Islet and into 
droplet formation channel (see Figure 2.4B).  A step change from the Islet 
produced a 1.8 s rise time before droplet generation and transport (see Figure 
2.4C).  Thus, in principle this system could achieve excellent temporal resolution 
for Islet monitoring.   
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Figure 2.4. Temporal response of step changes in concentration at the perfusion inlet and Islet 
surface from experimental results and numerical models.  The device was geometrically simplified 
to the regions of interest on the chip including the perfusion mixing channel, Islet chamber and 
reagent addition channels prior to T-junction for droplet formation (a).  Time lapse images of a 
simulated concentration profile slice at half channel height for a 1 s pulse of insulin release from 
an Islet show efficient sampling in (b).  Results, normalized for concentration and start frame, 
from the numerical model (c) and experiments with dye (d) are plotted as a function of time.  In 
the numerical model (c), a step change at the Islet surface (solid black line) resulted in 1.8 s rise 
time; however, a step change in concentration at the perfusion inlet yielded a 4.8 s 10 to 90% rise 
time at the end of the mixing channel (dashed black line) that increased to 8.1 s after the Islet 
chamber and reagent addition (dashed grey line).  Experimentally determined rise times from dye 
switching (d) yielded an 8.5 s 10 to 90% rise time at the end of the mixing channel (empty 
squares) that increased to 11 s after the Islet chamber and reagent addition (black circles) and to 20 
s when measured in multiphase flow in capillary (stars) with an expansion in the inset.  For 
comparison, the rise time for non-segmented flow system run under the same flow rates is shown 
(solid black line). 
 
To further evaluate the temporal performance of the device, we considered 
how different steps in the measurement process contributed to temporal distortion 
using both modeling and measurements of dye fronts at different points in the 
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chip created by making step changes in dye at the perfusion inlet.  The total 
temporal resolution can be considered the sum of the variances (τ2) from 
pumping, pre-plug convection and diffusion on chip, and droplet 
formation/transport components [43, 44].  Results from numerical models 
predicted that a step change in concentration made at the perfusion mixing 
channel inlet broadens to 4.8 s (10 to 90% rise time) before reaching the Islet 
chamber (Figure 2.4C, dashed black line).  This rise time increased to 8.1 s after 
the Islet chamber and reagent addition channels (Figure 2.4C, dashed grey line).  
These results suggest a 6.5 s of broadening prior to droplet formation and 
transport into the capillary based on summing the squares of the temporal 
contributions (see Figure 2.4C).   
To confirm the validity of numerically modeled broadening, broadening of 
step changes in fluorophore pumped through the system were measured and 
compared to the model.  In general good agreement was found.  Experimental 
data from imaging showed a 7.0 s contribution (6.5 s from numerical modeling) 
from the increase in rise time after the Islet chamber and reagent addition (see 
Figure 2.4D).  As a sum of squares this 7.0 s increase corresponds to a 2.5 s 
increase from 8.5 to 11 s of the total rise time of the analytical system.  However, 
the system’s response time increases to 20 s when measured in droplets at the 
detection window of the capillary.  The post-plug increase in response time is 
caused by droplet breakup and fusion at the large, rough drilled access hole and 
capillary connection.  Therefore, imperfections in droplet manipulation ultimately 
limited the temporal performance of this device.  
 30 
Nevertheless, it is apparent that plug flow allowed the creation of discrete 
samples with fixed concentrations of reagent that cannot mix with each other; 
specifically, this temporal quantization of plug flow is advantageous in preserving 
temporal resolution for monitoring cellular function via secretory species 
concentration dynamics even though the sample must be transported a significant 
distance to a detector and a sufficient incubation time is necessary for the assay.  
As a demonstration of this effect, if no droplet formation is used, the broadening 
is about 90 s (see Figure 2.4D, solid black line). 
 
3.3 Monitoring Islet Function 
To demonstrate the use of the system for monitoring cellular function, we 
exposed Islets maintained in the sample chamber to step increases in glucose and 
monitored the insulin content of resulting plugs.  Traces from several such 
experiments are illustrated in Figure 2.5.  Islets exhibited a characteristic burst of 
insulin followed by elevated secretions over basal levels when exposed to 
increased glucose [45, 46].  In some experiments, basal concentrations were not 
detectable at the flow rates used.  Therefore, to determine basal concentration we 
slowed the flow rates to half, thus achieving higher concentrations in the sample.  
From these measurements, average peak insulin secretions were 124 ± 19 pg/min 
(n = 7).   Basal insulin levels were near or below the detection limit such that they 
were not quantified; however, the presence of insulin the perfusate was confirmed 
by lowering the flow rate, illustrating the trade off between sensitivity and 
temporal resolution.   The Islets also displayed a variety of insulin secretion 
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dynamics that have been previously observed.  These include an initial burst 
phase of insulin release (Figure 2.5), slow oscillations with period of 2-5 min 
(Figure 2.5D) and more rapid fluctuations with period of ~ 20 s (Figure 2.5C).  
Such rapid fluctuations are expected but have been difficult to measure by other 
methods. 
 
Figure 2.5. Sample traces of insulin secretion measured by FPIA in segmented flow from 4 
individual Islets treated with step changes in glucose concentration (a-d).   
 
The automated perfusion system used here allowed cycling between high 
and low glucose concentrations as well (see Figure 2.5A, B, C).  These results 
show a decreased intensity of peak insulin bursts on the second stimulation.  This 
decreased release is possibly due depletion of insulin secretory granules near beta-
cell membranes by previous stimulated release [46].   
Previously reported microfluidic platforms for Islet monitoring have 
achieved detection limits as low as 0.8 nM [33] or have used segmented flow 
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sampling for temporal resolution limited only by flushing the sample chamber [5].  
These systems all required comparatively expensive imaging systems (microscope 
with camera compared to a single point detector) and were constrained in 
flexibility of glucose (or other chemical) concentration changes.  Easley 
demonstrated a segmented flow system with indirect measurements of insulin 
secretion with dyes [47] (e.g. Fluo-4) that can be realized with a single point 
detector but assume a 2:6 Zn2+:insulin secretion ratio; however, changes the 
chemical gradient supplied to the Islet caused interruptions in quantitative 
measurements.      
 
4. Conclusions 
 Although FPIA has been demonstrated on a continuous flow microfluidic 
device[48], this work demonstrates that FPIA can be performed in a plug-flow 
system by mixing immunoassay reagents on-line with sample prior to plug 
formation and then monitoring the anisotropy of plugs within the tube.  Rapid 
mixing in droplets eliminated the need for complex fabrication of mixing 
channels and preserved temporal resolution from sampling to quantification.  This 
assay adds the types of assays that can be performed in plugs.  The assay was 
applied to monitoring insulin from single Islets at high temporal resolution; 
however, as FPIA and other fluorescence polarization methods are commonly 
used for measuring drugs, hormones, and small molecule-protein interactions, this 
approach may prove useful when low volume and high-throughput is required 
such as clinical assays or high-throughput screening.   
 33 
While several segmented flow devices that improve temporal resolution 
over continuous flow devices have been recently reported, we demonstrate a 
versatile analytical technique for measuring a range of pharmacologically relevant 
compounds with a simple detection method.  This microfluidic device both 
improved temporal resolution by generating gradients near to the biological 
sample and by segmenting flow shortly downstream from the biological sample. 
This method allowed fast pulsatile insulin release from Islets to be measured.  
Numerical and analytical results suggest further improvements in temporal 
resolution are limited by the pumps and chip to capillary connections used in this 
work.  Future experiments with continuous multiphase flow FPIA can also be 
scaled to samples accessible with microfluidics (from single cell to tissue), 
multiplexed with contrasting dyes or multiple channels, or remotely sampled by 
storing water in oil droplets in a cartridge prior to analysis. 
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CHAPTER 3 
 
MICROFLUIDIC BIPOLAR ELECTRODE PRE-CONCENTRATION IN 
HIGHLY CONDUCTIVE MEDIA 
 
1. Introduction 
The quantification of neurotransmitters in vivo enables the direct study of the 
biochemical pathways in both normally functioning and diseased states of the brain [1].  
While numerous neurotransmitters are known to range from small molecules like nitrous 
oxides to large peptides like the endorphins, the low concentration of several of these 
biochemical species in the highly complex matrix of the central nervous system have 
frustrated efforts to directly study these pathways.   To reach levels of mass detection, 
either large a sample must be collected (which limits temporal resolution) or the samples 
concentrated prior to analysis [2, 3].   Several methods for pre-concentration have been 
reported, including solid phase extraction (SPE) [4-6], isoelectric focusing (IEF) [7, 8], 
temperature gradient focusing (TGF) [9, 10] and electric field gradient focusing (EFGF) 
[11-13].  Of preconcentration methods that can be continuously reused in a microfluidic 
device, the highest reported rate of enrichment reported is 108-fold in an hour from an 
EFGF method known as ion concentration polarization (ICP) [14]. 
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ICP, first observed by Rubinstein in desalination experiments with membranes, is 
a phenomenon in which bulk charge is primarily carried by either cations or anions at a 
greater flux than those ions are replaced such that localized region depleted of ions results 
[15-17].  This depleted region will have several implications for the electrochemical 
circuit: first, the electric field will have a larger gradient in the regions of concentrated 
ions that accumulate on either side of the depletion region; and, second, as the depletion 
region lowers the ionic strength of the solution sufficiently, the double layer formed by 
counterions at the charged surfaces of the walls will overlap inducing a permiselective 
region which only facilitates the transport of ions of the same charge as the double layer 
[18-24]. 
Two methods to engender ICP include the junction of a micro- and nano-channel 
under an electrical potential of sufficient strength to cause the double layers to overlap or 
by patterning a conductive material that is free to float in a channel of a microfluidic 
device.  This bipolar electrode (BPE) offers an alternate, lower resistance path for current 
that reduces the electric field near the electrode; additionally, the ends of the electrode 
allow water-splitting and other gas generating reactions to occur which will break the 
electrical circuit once comparable in size to the channel [8, 25-39].  To overcome this 
limitation, buffers are carefully chosen to reduce gas generation or that require lower 
potentials such as low ionic strength sample matrices.  In this chapter we will describe a 
microfluidic device that repeatedly pre-concentrates negatively charged peptides in 
highly ionic solution without bubble formation.   While a variety of quantification 
methods are compatible with this device, water-in-oil droplets were generated to store the 
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pre-concentrated peptides for compatibility with the quantification method described in 
the previous chapter. 
 
Figure 3.1. Scheme of bipolar electrode preconcentrator device where 100 µm channels in PMDS are 
bonded to a glass substrate with a Ti/Au electrode.   Aqueous sample driven by syringe pump into the main 
channel and oil driven (on demand) by pressurized air into two perpendicular channels were connected to 
the inlet reservoirs with 90-degree syringe tips.  Electrical potentials were applied from a DC source to the 
syringe tips at the aqueous inlet and outlet. 
 
2. Materials and Methods 
2.1 Chemicals and Solutions 
Fluorescein, sodium chloride, potassium chloride, magnesium sulfate, calcium 
chloride and phosphoric acid (both potassium and disodium salts) were purchased at the 
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highest purity from Sigma-Aldrich (St. Louis, MO).  Phosphate buffered saline (PBS: 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4) and artifical 
cerebral spinal fluid (aCSF: 145 mM NaCl, 2.68 mM KCl, 1.01 mM MgSO4, 1.22 mM 
CaCl2, 1.55 mM Na2HPO4, 0.45 Mm NaH2PO4, pH 7.4) solutions were prepared by 
dilution of reagents in 18 MΩ (MilliQ, Millipore, Bedford, MA) and pH adjusted with 
HCl.  Insulin, human recombinant from E Coli, fluorescent conjugate (Invitrogen, 
Carlsbad, CA) was diluted in PBS to 1.633 mM and stored protected from light at -5 C 
until use in experiments. 
 
2.2 Device Fabrication 
Polydimethylsiloxane (PMDS) fluidic layers were produced using normal 
lithographic techniques [40]; specifically, SU-8 2075 (Microchem, Newton, MA) was 
spun to 100 µm on mechanical grade 150 mm Si wafers and patterned by exposure to 
collimated UV light masked through a 56000 dpi transparency film (Fineline Imaging, 
Colorado Springs, CO) prior to development as per the manufacturers instructions.  Well-
mixed and degassed PDMS was poured over molds and cured at 100 °C overnight to 
cure.  After punching reservoirs through the PMDS layer with a biopsy punch, PMDS 
layers were plasma bonded (Electrotechnic, Chicago, IL) to glass slides with liftoff 
patterned 1 mm wide 50/250 Å Ti/Au electrodes. 
 
2.3 Fluidic Control 
Aqueous solutions were driven by syringe pump (CMA Microdialysis, Solna, 
Sweeden) connected via Teflon® tubing connected to 90-degree syringe tips inserted into 
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inlet reservoirs in the PDMS layer of devices; similarly, oil channels were driven by 
computer controlled pulsed air in Teflon® tubing connected to 90-degree syringe tips 
inserted to oil inlet reservoirs in the PDMS layer.  While aqueous solutions were 
continuously delivered at volumetric flow rates from 0.2 to 10 µL/min, oil solutions were 
only driven on-demand as controlled by an in-house written VI (LabView 8.5, National 
Instruments, Austin, TX). 
 
2.4 Electrical Control 
Electrical fields were applied by adjusting M10-S500 power supplies (American 
Power Design, Windham, NH) to desired voltages with an HHM 93 digital multimeter 
(Omega, Stamford, CT) and then clipping the power supply anode and cathode at the 90-
degree syringe tips inserted into the inlet and outlet reservoirs, respectively.  Potentials 
above 600 V were achieved by connecting power supplies in series. 
 
2.5 Experimental and Image Analysis 
Concentration experiments were imaged on a SZH10 stereoscope (Olympus 
America, Center Valley, PA) with 480 nm band-pass filtered BH2-RFL-T3 Hg arc lamp 
(Olympus America, Center Valley, PA) excitation.  Images for quantification were 
collected with a Andor Newton ECCD camera and calibrated by average photon counts 
per pixel as measured with serial dilutions of fluorescein standards (1 mM, 1 µM, 1 nM, 
1 pM, and 1 fM, specifically).  Image analysis was performed in ImageJ (NIH, Bethesda, 
MA). 
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3. Results and Discussion 
3.1 Ion Concentration Polarization via a Floating Bipolar Electrode 
To maintain an open circuit by preventing bubble formation the flux of gas 
diffusing out of the channel must be greater than the formation of gasses in the channel.  
While the flux of gases out of the channel is increased by the use of gas permeable 
substrates such as polydimethylsiloxane (PDMS), vacuuming PDMS increases this flux 
and is known to prevent bubble formation [41].  Specifically, we observed that storing the 
devices in vacuum to evacuate the gasses from the PDMS allowed the application 
potentials as high as 2 kV in media of >150 mM ionic strength in excess of 1 hour 
without observable bubble formation. 
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Figure 3.2. Time-lapse images (a) of ICP effect of 100 nM FITC-insulin in aCSF at 600 V in a 100 µm 
wide PDMS channel.  Plots of enrichment factor of 1 mM and 1 µM (b) and of 1 nM, 1 pM and 1 fM (c) 
FTC-insulin in PBS as a function of time under an electric field of 250 V. 
 
3.2 Media, flow rate, and voltage on enrichment 
Several parameters including media, bulk flow rate, and voltage were considered 
in optimizing devices for concentration of neuropeptides sampled from microdialysis.  
First, while the high ionic strength sample media of aCSF limits the rate of enrichment 
due to the high conductivity in the channel [26, 29, 32], dilution of the sample both 
increased the analysis time and yielded lower final concentrations of dyes for a given 
enrichment period.  For example, a 1 nM FITC-insulin in aCSF was enriched to 1 mM 
with 30 min, where the same sample diluted by a factor of 10 required over 1 hour to 
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reach the same fluorescent intensity.  Similar results were observed with dilutions of 
PBS, such that undiluted samples were used. 
Second, the bulk flow rate of sample introduction was tested with a range of 
microdialysis flow rates used in similar in vivo experiments; specifically, in the range of 
0.2-10 µL/min.  While higher flow rates are known to have lower relative recovery due to 
the shorter exposure to the diffusive region of the probe, the total flux of sampled species 
increases with flow rate as the larger chemical gradient into the probe linearly increases 
the rate of diffusion.  Experimental limitations of syringe pump speeds and tissue damage 
generally limit flow rates to <10 µL/min.  Both the stability of the location of the 
concentrated band generated and rate of enrichment increased linearly with increasing 
flow rate such that 10 µL/min was found to be the optimal bulk flow rate. 
Third, voltages from zero to 1200 V were tested by quantification of enrichment 
of a 10 nM FTC-insulin after 10 minutes of applied voltage (see Figure 3.3).  Where no 
enrichment was observed in the absence of an electric field, the rate of enrichment 
increases linearly with respect to electric potential at values below 400 V.  Rates of 
enrichment did not significantly vary at voltages above 400 V suggesting that enrichment 
was limited either by the rate of redox reactions at the BPE or delivery of sample by bulk 
flow. 
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Figure 3.3. Enrichment factor of 100 nM FITC insulin in PBS as a function of voltage applied after 10 
minutes. 
 
3.3 Rate of Enrichment 
Several factors including but not limited to the ionic strength of the solution, 
choice of buffer, electrical potential applied and initial concentration effect the rate of 
enrichment of charge species in the BPE concentrators studied.  While the application to 
neuropeptide pre-concentration limits the sample matrix to high ionic strength and sub 
nM concentrations of analytes, a 250 V potential was used test the feasibility of multiplex 
pre-concentrator with low power consumption.  As previously reported, highly 
concentration solutions appeared to enrich more slowly than analytes initially present in 
trace amounts (see Figure 3.2); however, as 1 mM fluorescein was near the solubility 
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limit in PBS and was calibrated to within an order of magnitude of maximum signal from 
the detector, saturation occurred within 5 minutes such that the rate could not be 
quantitatively measured. 
Approximation of enrichment as a function of time yielded fits with coefficients 
of determination of 0.995 or greater; specifically, rates were calculated by applying a 
Gaussian linear regression of extrapolated concentrations as a function of time with the 
electrical circuit active.  Under a 250 V potential, devices enriched 1 µM FITC-insulin at 
a rate of 3041 ± 29-fold/s.  This rate increased to 6218 ± 132-fold/s for 1 nM and 
increased to 25039 ± 246-fold/s for 1 pM FITC-insulin.  Following this trend of more 
rapid enrichment at lower initial concentrations, 1 fM FITC-insulin was enriched at a rate 
of 49300 ± 1330-fold/s.   While previous reports have suggested the initial concentration 
of analyte effects enrichment rates due to changes in the ionic strength of the media, the 
low relative (> 1%) contribution to ionic strength of the sample matrix illustrate the initial 
ionic strength is not the main contribution to this phenomena. 
 
3.4 Droplet Generation and Capture of Band 
To optimize the capture of bands in water-in-oil plugs, the location of the band 
after 1 hour of concentration was observed to occur within 1.7 to 2.5 mm (varied between 
devices) upstream of the cathode end of the BPE.  The fluidic layers of devices were 
bonded such that oil channels, perpendicular channels to the concentration channel, 
would be located on either side of this concentration region.  Droplets were generated at a 
variety of sizes as a function of spacing the oil inlet channels during fabrication such that 
5, 10 and 20 nL volume droplet devices were tested.  Droplets were produced as 5.62 ± 
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0.65 nL, 10.32 ± 0.48 nL and 20.57 ± 2.60 nL droplets as approximated as rectangular 
plugs from imaging. 
Sequestration of enriched bands in water-in-oil droplets was manually triggered 
with relative reproducibly in 5 nL and larger droplets (see Figure 3.4).  To ensure the 
highest enrichment the droplet must be large enough to encapsulate the entire band while 
excess volume of the droplet beyond this size will linearly dilute the enriched region.  In 
the case of 5 nL droplets, an efficiency of 58.4 % capture of the concentrated band 
lowered the effective enrichment to 5953-fold.  While 10 nL droplets increased in 
efficiency of droplet capture to 94.7 % and 20 nL droplets retained 98.7 % of the 
enriched band total fluorescence after droplet generation, the 10 nL droplet resulted in a 
5022-fold enrichment over the 3021-fold in the more dilute 20 nL droplet.  Droplet 
volumes with less than twice the length of the enriched band were experimentally 
difficult to manually confine into water-in-oil plugs.  Experimentally, the use of smaller 
droplets resulted in the most concentrated plugs of pre-concentrated sample despite high 
loss (>25%) of enriched ions due to convective flow during droplet generation. 
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Figure 3.4. Time-lapse images with bright-field and fluorescent illumination of enriched band immediately 
before (b) and after droplet generation (c) show compression of the band during droplet generation.  
Contrast enhanced fluorescent images of the initial sample solution (a) and droplet with captured enriched 
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band (d) for 1 nM FITC-insulin in PBS after 30 min enrichment at 250 V illustrates the relative pre-
concentration of samples.  In the bar graph (e), the total fluorescence of the enriched region (dark) before 
and after droplet generation and transport to the exit reservoir (grey) shows the relative efficiency of 
droplet capture as a function of volume. 
 
4. Conclusions 
 In this chapter we present the first microfluidic pre-concentrator with segmented 
flow (water-in-oil droplet) sequestration.  Where this droplet storage is directly 
compatible with the fluorescence polarization immunoassay quantification discussed in 
the previous chapter, this device enables the quantification of any biochemical species 
with commercially available antibodies.   Droplet sequestration of concentrated bands of 
analytes additionally allows storage for further analysis. 
 While improvements in future generations of devices allow room for 
improvements in capture efficiency by changing the geometry, the device reported 
achieved enrichment of a negatively charged protein in highly ionic media on the order of 
50000 in 1 hour with capture efficiency as high as 99%. 
 
 
 
 
 
 
 
 
	   49	  
 
 
 
References 
[1] B. Kolb, I.Q. Whishaw, Fundamentals of Human Neuropsychology, Worth 
Publishers, New York, 2003. 
[2] D.L. Robinson, A. Hermans, A.T. Seipel, R.M. Wightman, Chemical Reviews, 
108 (2008) 2554. 
[3] C.J. Watson, B.J. Venton, R.T. Kennedy, Analytical Chemistry, 78 (2006) 1391. 
[4] W. Chang, T. Komazu, T. Korenaga, Analytical Letters, 41 (2008) 1468. 
[5] R.D. Oleschuk, L.L. Shultz-Lockyear, Y. Ning, D.J. Harrison, Analytical 
Chemistry, 72 (1999) 585. 
[6] J.D. Ramsey, G.E. Collins, Analytical Chemistry, 77 (2005) 6664. 
[7] O. Hofmann, D. Che, K.A. Cruickshank, U.R. Müller, Analytical Chemistry, 71 
(1998) 678. 
[8] J. Wen, E.W. Wilker, M.B. Yaffe, K.F. Jensen, Analytical Chemistry, 82 (2010) 
1253. 
[9] D. Ross, L.E. Locascio, Analytical Chemistry, 74 (2002) 2556. 
[10] S.M. Kim, G.J. Sommer, M.A. Burns, E.F. Hasselbrink, Analytical Chemistry, 78 
(2006) 8028. 
[11] W.S. Koegler, C.F. Ivory, Journal of Chromatography A, 726 (1996) 229. 
[12] K.M. Balss, W.N. Vreeland, P.B. Howell, A.C. Henry, D. Ross, Journal of the 
American Chemical Society, 126 (2004) 1936. 
	   50	  
[13] P.H. Humble, R.T. Kelly, A.T. Woolley, H.D. Tolley, M.L. Lee, Analytical 
Chemistry, 76 (2004) 5641. 
[14] Y.-C. Wang, A.L. Stevens, J. Han, Analytical Chemistry, 77 (2005) 4293. 
[15] I. Rubinstein, L. Shtilman, Journal of the Chemical Society, Faraday Transactions 
2: Molecular and Chemical Physics, 75 (1979) 231. 
[16] I. Rubinstein, Journal of the Chemical Society, Faraday Transactions 2: Molecular 
and Chemical Physics, 77 (1981) 1595. 
[17] I. Rubinstein, Electro-diffusion of ions, Society for Industrial and Applied 
Mathematics, Philadelphia, 1990. 
[18] S.J. Kim, Y.-C. Wang, J.H. Lee, H. Jang, J. Han, Physical Review Letters, 99 
(2007) 044501. 
[19] D. Stein, M. Kruithof, C. Dekker, Physical Review Letters, 93 (2004) 035901. 
[20] N.A. Mishchuk, P.V. Takhistov, Colloids and Surfaces A: Physicochemical and 
Engineering Aspects, 95 (1995) 119. 
[21] F.C. Leinweber, U. Tallarek, Langmuir, 20 (2004) 11637. 
[22] A. Plecis, R.B. Schoch, P. Renaud, Nano Letters, 5 (2005) 1147. 
[23] K.P. Singh, M. Kumar, Journal of Physical Chemistry C, 115 (2011) 22917. 
[24] T. Yasui, N. Kaji, M.R. Mohamadi, Y. Okamoto, M. Tokeshi, Y. Horiike, Y. 
Baba, ACS Nano, 5 (2011) 7775. 
[25] E. Sheridan, D. Hlushkou, R.K. Anand, D.R. Laws, U. Tallarek, R.M. Crooks, 
Analytical Chemistry, 83 (2011) 6746. 
[26] R. Dhopeshwarkar, D. Hlushkou, M. Nguyen, U. Tallarek, R.M. Crooks, Journal 
of the American Chemical Society, 130 (2008) 10480. 
	   51	  
[27] D. Hlushkou, R.K. Perdue, R. Dhopeshwarkar, R.M. Crooks, U. Tallarek, Lab on 
a Chip, 9 (2009) 1903. 
[28] D.R. Laws, D. Hlushkou, R.K. Perdue, U. Tallarek, R.M. Crooks, Analytical 
Chemistry, 81 (2009) 8923. 
[29] R.K. Perdue, D.R. Laws, D. Hlushkou, U. Tallarek, R.M. Crooks, Analytical 
Chemistry, 81 (2009) 10149. 
[30] S.J. Kim, S.H. Ko, K.H. Kang, J. Han, Nature Nanotechnology, 5 (2010) 297. 
[31] J. Lee, J. Han, Microfluidics and Nanofluidics, 9 (2010) 973. 
[32] F. Mavre, R.K. Anand, D.R. Laws, K.-F. Chow, B.-Y. Chang, J.A. Crooks, R.M. 
Crooks, Analytical Chemistry, 82 (2010) 8766. 
[33] R.K. Anand, E. Sheridan, D. Hlushkou, U. Tallarek, R.M. Crooks, Lab on a Chip, 
11 (2011) 518. 
[34] R.K. Anand, E. Sheridan, K.N. Knust, R.M. Crooks, Analytical Chemistry, 83 
(2011) 2351. 
[35] C.-H. Chen, A. Sarkar, Y.-A. Song, M.A. Miller, S.J. Kim, L.G. Griffith, D.A. 
Lauffenburger, J. Han, Journal of the American Chemical Society, 133 (2011) 10368. 
[36] L.F. Cheow, J. Han, Analytical Chemistry, 83 (2011) 7086–7093. 
[37] P. Dextras, K.R. Payer, T.P. Burg, S. Wenjiang, W. Ying-Chih, H. Jongyoon, S.R. 
Manalis, Microelectromechanical Systems, Journal of, 20 (2011) 221. 
[38] I. Dumitrescu, R.K. Anand, S.E. Fosdick, R.M. Crooks, Journal of the American 
Chemical Society, 133 (2011) 4687. 
[39] A. Sarkar, J. Han, Lab on a Chip, 11 (2011) 2569. 
	   52	  
[40] J.C. McDonald, D.C. Duffy, J.R. Anderson, D.T. Chiu, H. Wu, O.J.A. Schueller, 
G.M. Whitesides, Electrophoresis, 21 (2000) 27. 
[41] J. Monahan, A.A. Gewirth, R.G. Nuzzo, Analytical Chemistry, 73 (2001) 3193. 
 
 
	   53	  
 
 
 
CHAPTER 4 
 
SUMMARY AND FUTURE DIRECTIONS 
 
1. Summary 
 The research presented in this dissertation focuses on developing quantitative 
analytical instrumentation; specifically, we have developed both novel and improved 
existing analytical instrumentation to quantify small, trace biologically active species 
from in vivo sampling.  A broadly versatile and robust immunoassay technique quantified 
cellular secretions while retaining temporal resolution with segmented flow generated on 
a microfluidic device. 
 
1.1 Quantitative Immunoassay 
 A non-destructive competitive immunoassay was developed to be compatible 
with droplet-based microfluidics.  At the bench scale, FPIA is a robust quantitative 
measure that has been demonstrated to be broadly applicable to a wide variety of analytes 
including commercial available systems such as Abbot’s RDx.  While detection of 
fluorescence anisotropy was previously demonstrated on a microfluidic device, the 
immunoassay was prepared at the bench scale and not applied to a biological system.   As 
reported (see Chapter 2), we optimized an FPIA for use in monitoring insulin secretions 
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from on-chip cultured Islet of Langerhans with a 5 nM detection limit and dynamic range 
up to 1 uM.  Temporal resolution of perfusion sampling was retained by immediate 
segmentation of flow on-chip into water-in-oil droplet; moreover, segmented flow was 
both experimentally and numerically demonstrated to improve the temporal resolution of 
two orders of magnitude such that sub-minute oscillations in glucose stimulate insulin 
release were observed in some experiments.  While the specific antibody-antigen 
complex will affect the detection limit and dynamic range of the FPIA, this system serves 
as a model for neuropeptide quantification. 
 
1.2 On-chip Preconcentration of Analytes 
 Preconcentration of fluorescently labeled insulin in highly ionic media was 
demonstrated via ICP induced by a potential applied across a microfluidic channel with a 
BPE.  While ICP has been previously demonstrated to enrich samples by factors as high 
as one-million-fold, we report a robust BPE preconcentator that is compatible with highly 
ionic media.  This in-line precocentration of insulin resulted in enrichment factors as high 
as 50,000-fold in an hour.  While insulin was larger than many neuropeptides in mass, 
both have similar electrostatic charge and electrophoretic mobility (within an order of 
magnitude) such that it serves as a model system for neuropeptide quantification.  Water-
in-oil droplet segmentation was generated on-demand to prevent dilution by dispersion; 
specifically, droplets generated at or greater than 10 nL captured the concentrated band 
with greater than 90% efficiency.  This preconcentration and droplet sequestration device 
was compatible with the FPIA quantification system discussed above. 
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2. Future Directions 
 The microfluidic devices developed in this dissertation were compatible with 
microdialysis sampling of neuropeptides.  In future work, these preconcentration and 
FPIA detection devices may be integrated together with microdialysis sampling.  While 
microdialysis sampling recovers analytes at low concentrations when operated at high 
flow rates, this lower concentration improves mass sensitivity.  Specifically, both the 
higher flux of analytes through the BPE device and higher rate of enrichment for more 
dilute analytes decrease the time to reach the nM detection limits of the FPIA.   
Concentration with BPE may also be multiplexed such that while a volume of sample is 
preconcentrated, another volume is simultaneously collected. 
 Several neuropeptides, namely opioid peptides, are of interest in the study of 
several disease states such as Parkinson’s disease as well as to function in signaling 
pathways of pain and reward.  The integrated microfluidic device described above offers 
a low cost method of in-line quantification of these and other neurotransmitters in 
microdialysis sampling for rodent models. 
 Optimization of preconcentration and droplet sequestration by modification of the 
location of the oil channels to decrease to final droplet volume additionally offers 
improvements in capture efficiency.  These improvements in capture efficiency increase 
the final concentration in the droplet such that the nM detection limits of the FPIA would 
be achieved in shorter concentration timescales.   Droplet based FPIA quantification 
offers a promising on-chip detection of small biologically relevant species. 
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APPENDIX A 
 
FLOUROGENIC ENZYMATIC QUANTIFICATION OF GLUCOSE AND 
FINITE ELEMENT METHOD MODELING OF MASS TRANSPORT AND 
FLUIDICS OF IN VIVO MICRODIALYSIS SAMPLING 
 
1. Context 
 In an effort to develop a quantitative analysis that would be compatible with 
microdialysis sampling, water-in-oil droplet storage and non-destructive analysis a 
variety of techniques were investigated including enzymatic fluorogenic analysis.  A 
bench-scale quantitative assay was optimized for biologically relevant concentrations of 
glucose prior modifications made for on-chip analysis.  The effect of membrane 
thickness, probe size and flow rate were numerically modeled with the finite element 
method commercially available software suite COMSOL.  Numerical and experimental 
results were compared to determine the relative contributions from the three parameters 
discussed above.  The sections (excerpts) below were previously reported both in M 
Wang’s dissertation and a published manuscript (“Improved Temporal Resolution for in 
Vivo Microdialysis by Using Segmented Flow” by Meng Wang, Gregory T. Roman, 
Kristin Schultz, Colin Jennings, and Robert T. Kennedy in Analytical Chemistry, 80 
(2008) 5607-5615): 
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2. Background 
Microdialysis sampling is widely used for in vivo monitoring of chemicals in 
extracellular space of tissues such as heart, fat, liver, and brain [1-3]. In chemical 
monitoring applications, temporal resolution is a key figure of merit because analyte 
concentrations can change rapidly [4-6]. When using microdialysis sampling, temporal 
resolution is usually limited by mass sensitivity of the analytical method coupled to the 
probe i.e., sample must be collected long enough to obtain a detectable quantity.  When 
techniques such as HPLC are used, the temporal resolution is often 10-30 min [7]; 
however, coupling microdialysis to nanoscale analytical techniques such as capillary 
electrophoresis (CE), microbore liquid chromatography (LC), and electrochemical 
sensors have shortened sampling times to seconds [4, 8-18].  
When using high sensitivity analytical methods, other factors can begin to limit 
temporal resolution achievable with microdialysis sampling.  One inherent limitation is 
broadening of sample zones due to Taylor dispersion as they are transferred from 
sampling probe to analytical system [19]. The effect of Taylor dispersion can be 
ameliorated by using high flow rate through the probe; however, this decreases relative 
recovery thus decreasing the concentration of analytes measured.  Higher flow rates are 
also incompatible with smaller probes and alternative sampling methods such as low flow 
push-pull perfusion [20] or direct sampling [21] that improve spatial resolution.  Taylor 
dispersion can also be decreased by shortening the length of tubing connections; 
however, this approach is impractical for experiments involving freely moving animals.  
Thus, although temporal resolution of 3 s has been described for sampling from an 
anesthetized animal at high dialysis flow rates; temporal resolution is increased to 90 s 
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for low flow rates or work with awake and freely moving animals [16].  In this work, we 
describe coupling microdialysis probes to a microfluidic segmented flow system to avoid 
these limitations.  Segmented flow can eliminate Taylor dispersion by localizing samples 
as aqueous droplets or plugs formed in a stream of water-immiscible carrier fluid [22-25].  
A surge of recent research into segmented flows has shown the potential of this 
approach for chemical measurement.  Droplets or plugs from femtoliter to microliter 
volume can be reproducibly created using a variety of microfluidic geometries including 
tee junctions [26], Y-junctions [23], and nozzles [27].  Furthermore, plugs can be 
manipulated for chemical analysis through reagent addition [28-30], rapid on-chip mixing 
[29-30], and transfer to outside tubing [29-32].  Recent applications of such systems 
include kinetic measurement [26, 33], synthesis [29, 34-35], protein crystallization [32, 
36], DNA analysis [37], PCR [38], cell sorting [39] and cell encapsulation [23, 40].  
Although avoiding dispersion or mixing of discrete samples is often cited as an advantage 
of segmented flow, this approach has not been described for chemical monitoring 
applications such as in vivo microdialysis. 
The goal of this study was to combine in vivo microdialysis sampling with a 
segmented flow microfluidic device to conserve temporal resolution while sample plugs 
were transported from the probe to a downstream detection system.  We determined 
conditions for obtaining dialysate flow segmentation on the scale needed for in vivo 
analysis, tested the effects of flow segmentation on temporal resolution, and 
demonstrated use of the system for analytical measurements by coupling it to an on-line 
enzyme assay for monitoring glucose in the brain of living rats.  We demonstrate that 
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temporal resolution of 15 s is possible and that this resolution is independent of both time 
to transport sample to the analytical system and dialysis flow rate.    
 
3. Materials and Methods 
3.1 Chemicals and Reagents 
All chemicals were used as received. Perfluorodecalin, fluorescein, 
hexamethyldisilazane (HMDS), octadecyltrichlorosilane (OTCS), n-hexadecane, and 
methanol were purchased from Sigma-Aldrich (St. Louis, MO).  Salts for artificial 
cerebral spinal fluid (aCSF) were purchased from Fisher Scientific (Chicago, IL).  A 
glucose assay kit consisting of Amplex® red reagent, dimethylsulfoxide (DMSO), 
horseradish peroxidase (HRP), glucose oxidase (GOX), D-glucose, concentrated reaction 
buffer (0.05 M sodium phosphate, pH 7.4), and H2O2 was purchased from Invitrogen 
(Carlsbad, CA).  All aqueous solutions were prepared with water purified and deionized 
to 18 MΩ resistivity using a Series 1090 E-pure system (Barnstead|Thermolyne 
Cooperation, Dubuque, IA).  
 
3.2 LIF Detection and Data Analysis 
For visual inspection and monitoring of sample plugs, the chip or collection 
capillary was mounted on a Nikon inverted microscope (Eclipse TS100, Melville, NY).  
Photographs were taken through the microscope using a digital camera (FinePix F30, 
Fujifilm, Japan).  When detecting fluorescence, the collection capillary or chip was 
mounted on an epi-illumination inverted microscope (Axiovert 100, Carl Zeiss Inc.).  
Fluorescence was excited using a 488 nm line of an Ar+ laser (Melles Griot, Carlsbad, 
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CA) for fluorescein or the 543.5 nm line of a He-Ne laser (Melles Griot, Carlsbad, CA) 
for Amplex® red.  Fluorescence was collected through a 10x objective through 
appropriate filter sets and detected using a photometer (R3896, Hamamatsu Photonics, 
Bridgewater, NJ) mounted on the microscope.  The photometer was set to low pass filter 
at 250 Hz.  Fluorescence signals were collected via a data acquisition card (PCI-6036E, 
National Instruments, Austin, TX) at 1000 Hz using LabView program written in-house.  
Microsoft Excel 2007 (Microsoft, Redmond, WA), Igor Pro 6.01 (Wavemetrics, Inc., 
Lake Oswego, OR), and Cutter 7.0 [50] were used for data analysis and graphing. 
 
3.3 Computational Modeling of Microdialysis Sampling 
Microdialysis probe sampling dynamics were modeled using COMSOL 
Multiphysics ® 3.3 (Comsol, Inc., Burlington, MA).  1 and 2 mm long probes were 
approximated as 200 µm wide cylinders with a 40 µm i.d. by 100 mm o.d. capillary 
inserted to within 50 µm of the bottom of the probe, a similar capillary outlet at the top of 
the probe and a 10 µm thick membrane.  The boundary layer (i.e., quiescent solution) 
around the probe was approximated to be 50 µm thick for a well stirred solution 
(assuming Re ~ 100) [51].  Diffusion was treated as uniform throughout the boundary 
layer, membrane and probe volume.  All models were solved in three dimensions by 
modeling mass transport from the edge of the boundary layer into the perfusing flow into 
the probe as a function of time for 1 minute.  The net concentration out of the probe was 
fit to a Hill equation by nonlinear regression using Origin® 6.0 (Microcal Software, Inc., 
Northhampton, MA) to generate data traces.  The outlet capillary from the probe was 
modeled as a 3.5 cm long by 40 µm i.d. capillary in two dimensions.   Analyte 
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concentration and response times were determined from the time-dependent 
concentration profile at the end of the capillary model.  Constants used in the model were 
4.25×10-6 cm2/s as diffusion coefficient for fluorescein [52], 993 kg/m3 for density of 
water, and 6.90×10-4 Pa s for viscosity of water (37 oC).  Specifically, fluidic domains 
were solve first by setting outlet pressure to neutral and the inlet at a constant flow rate 
(either 0.2 or 2 µL/min depending on experiment).  Using the values stored from these 
results as constants, convection and diffusion was then modeled for 1 min with 0.01 s 
time steps by setting the inlet concentration at zero and holding the concentration at the 
outside of the boundary layer as 1 unit.  This process was first applied to the bottom 
section (slice) of the probe model and then repeated for each section above but fitting six 
concentric rings with the method described above from the outlets of the previous model.  
Concentration profile as a function of time was plotted in the figure below for both 1 and 
2 mm probes and at both 0.2 and 2 µL/min flow rates. 
 
3.4 In Vitro Glucose Assay 
Glucose assays were performed on-line by mixing reagents and dialysate within a 
chip to form sample plugs that were pumped to a detection zone in a collection capillary 
downstream of the mixing/plug formation point.  Reagents were prepared from stock 
solutions of Amplex® red (10 mM in DMSO), GOX (100 UI/mL in 0.05 M sodium 
phosphate reaction buffer, pH 7.4) and HRP (10 UI/mL in reaction buffer, as described 
above) according to vendor instructions.  Stock solution was stored frozen at -80 oC as 
single-use aliquots.  For each day’s experiment, stock solution aliquots were thawed on 
ice and then diluted with reaction buffer to produce separate enzyme (6 UI/mL GOX and 
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0.6 UI/mL HRP) and indicator (0.3 mM Amplex® red) solutions.  These working 
solutions were kept on ice and shielded from light by aluminum foil at all times.  To 
ensure activity of reagents, solutions were replaced every two hours.  
For on-line glucose assay, the aqueous inlet channel shown in Figure A.1A was 
modified to have 3 channels (one for HRP/GOX solution, one for Amplex® red solution, 
and one for dialysate) that merged to a single channel just before the tee intersection 
(details given in text).  The flow rate for sample stream was 200 nL/min and for each 
reagent stream 50 nL/min.  Oil flow rate was 1000 nL/min. With these flow rates, each 
plug was expected to contain the concentrations recommended by the vendor, i.e. 0.1 
UI/mL HRP, 1 UI/mL GOX and 50 mM Amplex® red.  To test and calibrate the on-line 
assay, glucose solutions with concentrations ranging from 0.1 mM to 5 mM were 
prepared in aCSF and sampled by microdialysis.  Fluorescence of each resulting sample 
plug was detected 40 cm downstream using LIF as described above.     
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Figure A.1.  (A) Illustration of microdialysis/segmented flow system used in this work.  Arrows indicate 
direction of flow.  Micrograph in inset illustrates plug generation at a tee junction.  (Aqueous stream 
contains food dye for visualization.)  Aqueous channels had a width of 125 mm and main channel with 
segmented flow had a width of 250 mm. (B) Dependence of plug volume on oil flow rate at different 
aqueous flow rates (Qw) for structure shown in Figure A.1A.  (C) Dependence of interval time between 
plugs on oil flow rate at Qw for structure shown in Figure A.1A.   
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4. Results and Discussion 
4.1 Effect of Flow Rates on Plug Volume and Time Interval 
In a sampling system with on-line analysis that uses segmented flow, the sample 
plug volume, interval between plugs, and plug generation frequency have a large impact 
on both the temporal information that can be obtained and the analytical methods that 
should be adopted.  The sample plugs must be large enough that the amount of analyte in 
them is higher than the mass detection limits of the analytical method.  Sample plug 
generation frequency sets the upper limit to temporal resolution obtainable, e.g. a system 
that generates one sample plug every 10 s will have a temporal resolution no higher than 
10 s.  If on-line analysis is used, then the interval between plugs that are created must be 
longer than the minimum time required for each analysis (e.g., separation time in LC).  In 
this work we used a microfluidic tee to segment flow from the dialysis probe.  As 
demonstrated previously [54-55], plugs generated in a tee can be controlled by changing 
relative flow rates of the sample and carrier fluid as well as dimensions of the channels.  
Although models have been developed to predict plug generation,54 we found that 
experimentation was required to obtain the desired plug formation dynamics.   
For this work, we sought to generate plugs from sample stream flow rates in the 0.1 
to 1 mL/min range at 1 to 10 s intervals to yield samples with low nanoliter volumes.  
This flow rate is typical for microdialysis and the plug formation frequency represents 
significant improvement in temporal resolution while generating plugs that are easily 
manipulated and analyzed.  As shown in Figure A.1, a tee with 125 × 80 mm inlet 
channel and 250 × 80 mm main channel allowed such plugs to be formed.  For a given 
sample flow rate, increasing the oil flow rate decreased plug volumes and intervals 
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(Figure A.1B and A.1C).  Decreasing the sample flow rate generated smaller plugs at 
longer intervals.  The dynamic range of intervals was approximately 0.6 to 10 s.  Plugs 
were reproducible with < 5% RSD in volume and < 8% RSD in interval time.  Chip 
dimensions could also be varied to yield different ranges that might be appropriate for 
different applications.  For example, with 50 × 12 mm channels we generated plugs of 50 
to 200 pL at < 1 s intervals.  In some cases, it may be desirable to independently control 
sample size and interval between plugs; however, this is not possible with the tee 
junction.  An active system where plugs are formed by a trigger would allow such 
independent control but would also necessitate a more complex instrument.    
 
4.2 Conservation of Temporal Resolution with Segmented Flow System 
After demonstrating controlled sample plug formation, we tested the potential to 
preserve temporal resolution in comparison to a continuous flow system during 
microdialysis sampling.  For these experiments, step changes in fluorescein concentration 
were made at the probe surface while recording response curves by LIF detection.  A 
dialysis flow rate of 200 nL/min was used representing a relatively low flow rate that 
generates high relative recovery (approximately 53% for glucose) but is usually not 
associated with good temporal resolution.  For the continuous flow system the oil flow 
was replaced by aCSF.  Recordings were made both near the tee junction and 40 cm 
downstream for both continuous flow and segmented flow (see Figure A.2A and A.2B).  
A comparison between upstream and downstream response curves for both systems 
demonstrates the advantage of segmented flow over continuous flow for conserving 
temporal resolution.  (Temporal resolution and response time in this discussion refer to 
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the time from the initial increase in signal to the steady state signal and does not include 
the delay time associated with flowing from the probe to the detection window.)  With 
segmented flow, on-chip and downstream detection produced response curves that 
exactly overlapped (Figure A.2C), verifying prevention of axial dispersion between plugs 
and conservation of temporal resolution after sampling.  In contrast, severe deterioration 
in temporal resolution, represented as a broadened transition zone, was observed with 
continuous flow (Figure A.2D), due to axial dispersion of sample zones during transport 
at low flow rate through a capillary.  
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Figure A.2.  Illustration of on chip and on capillary detection points for comparing temporal resolution of 
segmented flow (A) and continuous flow (B) systems.  Step change of fluorescein concentration from 50 
nM to 100 nM was made at the probe surface and response curves at the two detection points were recorded 
for segmented flow (C) and continuous flow (D).  For (C), the data points represent the maximal 
fluorescence recorded from each sample plug as it passed through the detector.  The top time axis is for the 
downstream (capillary) detection point and the bottom for the on-chip detection point in both graphs.  
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Sampling flow rate was 200 nL/min and cross-sectional flow rate (perfluorodecalin or aCSF) was 1 
mL/min.  Microfluidic chip conditions were the same as described in Figure A.1. 
 
We next explored the upper limits of temporal resolution with this system.  To do 
this, we repeated the step change experiment but with stirred solutions and probes 
equilibrated to 37 oC.  Stirring is expected to decrease the distance required for analyte to 
diffuse to the probe while the elevated temperature increases diffusion coefficients.  
Using this approach we observed response times of ~ 30 s (time from 10-90% of 
maximal signal) at 200 nL/min dialysis flow rates (see Figure A.3A).  Increasing the 
dialysis flow rate to 1 mL/min did not improve the temporal resolution (Figure A.3B).  
Decreasing the dialysis probe length by half to 1 mm resulted in an approximately 2-fold 
improvement in response time to 15 s at both flow rates (Figure A.3C and A.3D).  Thus, 
response time scaled with membrane length rather than flow rate.  These results suggest 
that mass transport across the membrane, and not Taylor dispersion, limits temporal 
resolution under these conditions.   
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Figure A.3.  Response obtained at both low and high sampling flow rate with microdialysis probes with 
different membrane lengths.  (A) 2 mm probe at 200 nL/min; (B) 2 mm probe at 1 mL/min; (C) 1 mm 
probe at 200 nL/min; (D) 1 mm probe at 1 mL/min.  Fluorescein concentration was changed from 2 mM to 
5 mM at the probe surface.  Cross-sectional flow rates were 1 mL/min for 200 nL/min sampling rate and 
were 4 mL/min for 1 mL/min sampling rate.  Data traces are raw output from LIF detector and show 
detection of individual sample plugs. Temporal resolution, defined as the time during which signals 
increased from 10% to 90% of the maximum intensity, is marked on each graph.  Chip conditions were the 
same as described in Figure A.1.   
 
To further explore this effect, we modeled the response of a dialysis probe to step 
changes in concentration in a stirred solution at 37 oC.  The model was based on the 
geometry of the probe (see Experimental section and Figure A.4A).  The system was 
considered to have a 50 mm boundary layer and diffusion coefficient within the 
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membrane was considered to be the same as solution.  These conservative estimates have 
the effect of making observed responses limited primarily by flow and diffusion within 
the probe and tubing and not transport across the membrane.  As shown in Figure A.4, 
this model predicts response times of 11.9 s for a 2 mm probe at 0.2 mL/min.  Increasing 
the flow rate to 1 mL/min decreased the response time to 3.5 s.   Cutting the probe length 
in half yielded a small decrease in response time to 8.0 and 2.1 s with 0.2 and 1 mL/min 
flow rates, respectively.  Thus, when the transport across the membrane is not limiting, 
the response times are 2 to 8-fold faster than those measured experimentally.  
Furthermore, in contrast to experimental results, the dialysis flow rate has a bigger effect 
on response time than membrane length.  This result further supports the conclusion that 
transport across the membrane is a limiting factor in response time in this system.  Lower 
effective diffusion coefficients within the membrane [19, 56], adsorption to the 
membrane, and flow leakage through the membrane are all factors that can slow transport 
and therefore alter response time.  Accurate knowledge of these processes would be 
required to correctly predict response times.  This work suggests that improved 
membranes or sampling without membranes, such as direct [21] or push-pull sampling 
[20], would be required to further improve the temporal resolution.   
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Figure A.4.   Simulation of response to step change in fluorescein concentration at a microdialysis probe 
using COMSOL.  (A) The geometry of the dialysis probe was the same as those used experimentally i.e., 
200 mm inner diameter, 220 mm outer diameter, side-by-side inlet and outlet capillaries and a 40 mm i.d. 
by 3.5 cm long exit capillary.  Curved arrow indicates direction of dialysis flow.  The steady state 
concentration gradient for unit concentration outside the probe is shown over the geometry in this 
illustration.  (B) The response shown is the concentration change at the outlet of the exit capillary following 
a step change from zero to unit concentration at time zero.  The probe lengths and dialysis flow rates are 
given in the legend.  
 
4.3 On-Chip Glucose Assay with Segmented Flow 
To demonstrate the potential of the microdialysis to segmented flow system for 
chemical analysis, we integrated an on-line glucose enzyme assay.  The sampling chip 
was modified with a triple-branch inlet to enable addition of assay reagents to the sample 
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stream 1 mm upstream of the plug formation point.  As illustrated in Figure A.5A, sample 
stream from the microdialysis probe flowed in the middle branch while enzymes (GOX, 
HRP) and dye (Amplex® red) were infused from the two side branches.  Sample stream 
flow rate was 200 nL/min while the reagent stream flows were 50 nL/min each.  This net 
flow rate resulted in sample plugs forming at 4 s intervals.  Mixing and enzymatic 
reaction took place to form a fluorescent product (see Figure A.5B for reaction scheme) 
within plugs as they were transported in a capillary from the microfluidic chip to 
detection window.  Reaction time could be adjusted by varying the length of the capillary 
as well as oil flow rate.  Although the assay kit suggested a 30 min incubation time before 
detection, we found that 17 min was enough to distinguish different glucose 
concentrations.  This reaction time could be achieved by a 40 cm capillary at 1 mL/min 
oil flow rate.  An illustration of the raw fluorescence signal from the plug enzyme assay 
at the detection point during a step change from 0.2 to 1 mM glucose is shown in Figure 
A.5C.  This trace illustrates the uniformity of signal intensities across different plugs for a 
given glucose concentration.  Indeed, the assay yielded 2.3% RSD (n = 56) at 1 mM 
glucose.  The assay also had a linear response up to 2 mM glucose and a detection limit 
of 50 mM glucose (see Figure A.5D). The trace in 5C also illustrates the preservation of 
temporal resolution for this experiment even though the sample plugs required 17 min for 
transport from the sampling to detection points.  This effect represents a substantial 
advantage of the segmented flow system for assays that require long reaction times.  This 
result further illustrates that the segmented flow system can maintain temporal resolution 
regardless of downstream processes.  
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Figure A.5.  Glucose assay with segmented flow system. (A) Micrograph of microchannel network used 
for enzymatic assay within plugs.  Food dye has been added to the Amplex® red and GOX/HRP streams for 
visualization.  (B) Reaction scheme for the enzymatic assay.  (C) LIF response when glucose concentration 
was changed at the probe from 0.2 to 1 mM.  The inset shows an amplified view of the trace.  Data are raw 
traces showing detection of individual plugs.  (D) Calibration curve for glucose sampled by microdialysis 
and assayed using this system.  Glucose concentrations are sampled concentrations.   
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Figure A.6.  (A) Overview of system for in vivo glucose assay.  (B) Time course of extracellular glucose 
concentration in the NAC of rats infused high K+ (100 mM) aCSF through the probe.  Time on axis is time 
since switch was made to high K+.  Black bar indicates application of K+ corrected dead volume of system.  
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Axis on the left is relative fluorescence unit (RFU) for the maximal signal in each plug while right axis 
expresses data as the percentage of basal glucose concentration. 
 
5. Conclusion 
Segmented flows have received significant attention in chemical analysis in recent 
years primarily for their potential in high-throughput analysis.  In this paper, we reduce to 
practice the possibility that microfluidic segmented flows can be used to prevent temporal 
distortion in a sampling and monitoring experiment.  Temporal resolution for 
microdialysis was maintained at 15 s regardless of downstream processes thus allowing 
good temporal resolution to be maintained for experiments requiring long connection 
capillaries (such as freely moving animals) or assays that involve long reaction times.  
The use of segmented flow with sampling represents a significant advance for sampling 
approaches because it decouples analysis time from the temporal resolution that is 
possible.  It also provides a convenient approach for manipulating nanoliter volume 
fractions that are generated with performing high temporal resolution measurements.  Our 
experiments suggest that future research aimed at improving temporal resolution should 
be directed towards improving sampling processes.  Furthermore, coupling to other assay 
systems will be important in allowing this approach to extend beyond enzyme assays.  
Extension of the method to other assays and coupled to different sampling probes will 
likely yield systems with temporal resolution that approaches that of many sensors. 
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APPENDIX B 
 
FINITE ELEMENT METHOD MODELING FLUID DYNAMICS AND MASS 
TRANSPORT IN AN ADIPOCYTE PERFUSION MICROFLUIDIC DEVICE 
 
1. Context 
 Many cells are known to respond to the fluidic environment; specifically, 
adipocytes, or fat cells, undergo low shear stress in natural conditions.  At the scale and 
complex geometry of microfluidic devices, physical parameters such as shear stress are 
analytically difficult to measure; however, these parameters may be calculated with 
commercially available finite element method software suites such as COMSOL.  In the 
work described below, both the stress that cells cultured in this devices and the mass 
transport of gradients to and from the cells were numerically modeled such that they 
provided good agreement with experimental measures.  Specifically, the Reynolds 
number (Re) was calculated for the cell chamber, where the diameter of the tube is 
approximated as DH = 4A/P: 
Re = ρVDH/µ 
such that at an 80 µL/min flow rate the Re was well below turbulent conditions (Re = 
5.93e-6) and flow was approximated as Laminar flow.  First, the fluid dynamics were 
solved by setting the outlet pressure to neutral and inlets at a constant flow rate that 
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summed to 80 µL/min in 3D with a nm mean free path length assuming a rectangular 
channel with dimensions of 400 by 5000 by 40,000 µm (see Figure B.1).  The density and 
viscosity of water were held constant at 1000 kg/m3 and 0.001 Pa s, respectively.  Shear 
stress was calculated throughout the chamber and found to be at a maximum value near 
the walls of the cell channel but with a value of 0.006 N m-2 at a probe location near the 
cells.  Second, using the stored values from the fluidic model, convection and diffusion 
was solved in 3D for a 90 s model with 0.1 s time-steps for the introduction of 
isoproterenol (D = 1e-9 m2/s) such that good agreement was found with analytical 
measures of pumping dyed glycerol into the cell channel.  Third, the sampling of glycerol 
secretions from the cells was modeled.  Assuming 1 nanomole of glycerol was secreted 
for every 10,000 cells and a bed of 50,000 cells per 0.0002 m2 (average from cell counts 
after culture), a flux of 4.17e-8 mol/m2 s was uniformly applied across the bed of the cell 
channel.  Using the literature value for the diffusion of glycerol (D = 7e-10 m2/s) and 
fluidic values calculated from the first model, a 1 s pulse, 30 s pulse and constant 
secretion were modeled for 300 s with 0.1 s time-steps (see Figure B.S1). 
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Figure B.S1. Normalized flux of glycerol secretions from a 1 s pulse (green), 30 s pulse (black) and 
constant release (red) from a packed bed of cells along the bottom of the cell channel. 
Moreover, the fluorogenic quantification describe herein was modified from 
protocol developed for glucose quantification (see Appendix A).  The excerpts below 
were previously published both in Dr A Clark’s dissertation and published manuscript 
(“Continuous-Flow Enzyme Assay on a Microfluidic Chip for Monitoring Glycerol 
Secretion from Cultured Adipocytes” by Anna M. Clark, Kyle M. Sousa, Colin Jennings, 
Ormond A. MacDougald, and Robert T. Kennedy in Analytical Chemistry, 81 (2009) 
2350-2356): 
 
2. Introduction 
Physiological studies frequently require maintaining cells or tissues in a 
controlled environment while detecting their physical, electrical, or chemical properties.  
Microfluidics may greatly facilitate such research by allowing creation of highly 
controlled cell-compatible environments integrated with sophisticated measurement and 
cell manipulation methods.   Examples of using microfluidics for cell physiology include 
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screening for ligand binding and reporter gene expression from immobilized cells using 
fluorescence microscopy [1], determining metabolic flux from electrically stimulated 
cells using amperometry [2], and characterizing drug dose-response using patch clamp 
methods [3]. Another common physiological method that may benefit from microfluidics 
is monitoring secretion of chemicals from perfused cells.  Without microfluidics, such 
studies are typically laborious as they require collection and subsequent chemical 
analysis of large numbers of fractions.  Microfluidics may improve perfusion and 
secretion measurements by reducing costs through reduction of reagent usage, allowing 
automated analysis, reducing cells required, improving throughput, allowing novel 
perfusion patterns, and improving temporal resolution [4-6].  
Several examples of using chips to monitor cellular secretions have been reported 
[7-13].  These include using electrophoretic immunoassay to measure insulin secretion 
from islets of Langerhans [7-8], amperometry to monitor catecholamine release from 
PC12 cells [9], and chemiluminescence to detect glucose and ethanol secretions from S. 
cerevisiae [10]. Enzyme assays have also proven to be a viable approach to monitoring 
cellular secretions on microfluidic devices.  Enzyme assays have been utilized on 
microfluidic devices to study metabolic secretions from preimplantation embryos [11], 
activity of expressed enzymes from E. coli cells [12], and immune response from 
macrophages [13]. 
In this study, we extend such measurements to near real-time monitoring of 
glycerol secretion from an adipocyte cell line (differentiated murine 3T3-L1 cells) [14-
15] using a continuous-flow enzyme assay.  The prevalence of obesity and obesity-
related disorders underscores the necessity to study and to understand adipocyte 
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physiology.  A primary function of adipocytes is to store and release energy.  Adipocytes 
store energy as triacylglycerol and release fatty acids and glycerol by lipolysis to supply 
energy for other tissues and organs.  Measurement of glycerol secretion is often used to 
ascertain the function and physiological state of adipocytes [16-19].  Studying adipocytes 
in microfluidic devices is hampered by several fat cell properties including high 
buoyancy, lengthy culture times (~2 weeks) to differentiate adipocyte cell lines, fragility 
of lipid-laden adipocytes, and secretion of hydrophobic moieties which are difficult to 
transport through PDMS-based devices.   Despite these difficulties, adipocytes have been 
differentiated [20-21], studied for incorporation of toxins [20, 22], and examined for size 
[23] on chips; however, integration of cultured adipocytes with chemical measurement of 
cellular secretions has yet to be performed.   
We have developed a dual-chip microfluidic system for culturing adipocytes, 
perfusing them, and then monitoring glycerol release using a continuous-flow fluorescent 
enzyme assay.  One chip was a cell perfusion chamber.  Cells grown on conventional 
cover slips could be loaded into the reversibly-sealed chip for perfusion experiments.  
These features allowed the chip to be reused and allowed cells to be cultured for long 
periods in conventional incubators prior to use.  The second chip was used for 
continuous-flow enzyme assay.  To achieve sufficient sensitivity, a commercially 
available absorbance-based enzyme assay for glycerol was converted to a fluorescence-
based enzyme assay by the inclusion of the hydrogen peroxide-sensitive dye Amplex 
UltraRed.  For actual measurements, the chips were coupled so that effluent from the 
perfusion chip was transferred to the enzyme assay chip allowing adipocyte secretions to 
be monitored on-line with 90 s temporal resolution.  The system was used to demonstrate 
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transient increases in glycerol secretion during exposure of the cells to isoproterenol, a β-
adrenergic agonist.  The ability to modify enzyme assays for fluorescence-based 
detection and analyze cells grown in culture on cover slips demonstrates the potential to 
monitor metabolite secretions in real-time from various cell types utilizing the 
microfluidic system presented. 
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Figure B.1. Schematics of the two microfluidic devices used in this work. (a) A diagram of the perfusion 
cell chip depicts the two separate wafers employed in this work.  The wafers were reversibly sealed with 
the aid of an in-house built compression frame. (b) A side view of the perfusion chip displays the cell 
chamber, which contained 50 000 differentiated adipocytes. Perfusion solution washed over the cells to 
sample secretions released from the cells.  (c) The enzyme assay chip was capable of performing on-line 
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mixing of three solutions and on-line detection of the enzymatic product.  The layout shows the initial 
mixing channel connected to the incubation channel. 
 
3. Materials and Methods 
3.1 Chemicals and Reagents 
Free glycerol reagent, glycerol standard solution, isoproterenol, dimethyl 
sulfoxide (DMSO), cell culture reagents, and 1x Hanks balanced salt solution (HBSS) 
were purchased from Sigma (St. Louis, MO).  Amplex UltraRed was purchased from 
Invitrogen (Carlsbad, CA).  All other chemicals were purchased from Fisher (Pittsburgh, 
PA).  Glycerol standards and the glucose solution perfused over cells were made using 
HBSS as solvent.  All other solutions were made using Milli-Q (Millipore, Bedford, MA) 
18-MΩ deionized water.  Solutions perfused through microfluidic devices were filtered 
using 0.2-µm nylon syringe filters (Fisher). 
 
3.2 Computational Modeling of Perfusion Chip 
The fluid flow dynamics of the perfusion cell chip were modeled using COMSOL 
Multiphysics 3.3 (Comsol, Inc., Burlington, MA). The flow was defined to be laminar 
and with a volumetric flow rate of 80 µL min-1.  Constants used in the model were 1 × 
10−9 m2 s-1 as diffusion coefficient for glycerol, 6.85 x 10-10 m2 s-1 as diffusion coefficient 
for isoproterenol, 993 kg m-3 for density of water, and 6.90 × 10−4 Pa s for viscosity of 
water (37 °C).  The cell chamber volume used was 4 cm long, 0.5 cm wide, and 0.04 cm 
deep (0.01 cm from the top wafer and 0.03 cm from the bottom wafer after accounting for 
the presence of the 0.015 cm thick cover slip).   
 
	   90	  
3.3 Enzymatic Assay and On-line Mixing 
A commercially available absorbance-based, enzyme assay (Free Glycerol 
Reagent, Sigma) for glycerol was converted to fluorescence-based detection by the 
inclusion of the hydrogen peroxide sensitive dye Amplex UltraRed resulting in the assay 
scheme shown in Figure B.2A.  Amplex UltraRed was diluted with DMSO to result in a 
100 µM solution upon on-chip mixing.  The glycerol enzyme reagent was reconstituted 
according to manufacturer’s instructors.  The enzyme reagent, which contained all 
necessary enzymes and co-factors, was mixed with dye and sample and allowed to react 
for 5 min prior to detection.   
To perform this assay on the microfluidic enzyme chip (Figure B.1C), sample or 
perfusate from the perfusion chip was transferred via capillary to the enzyme assay chip 
as a continuous flow.  The flow was split so that only 0.31% of the flow from the 
perfusion chip entered the enzyme chip with the rest going to waste.  The flow split was 
achieved using a Valco tee between the chips with the following capillary lengths and 
inner diameters for connection: 20 cm, 150 µm from perfusion chip to flow split; 10 cm, 
50 µm from flow split to enzyme chip; 7 cm, 150 µm from flow split to waste.  All 
capillary outer diameters were 360 µm.  The enzyme reagent and fluorogenic dye were 
each delivered to the enzyme assay chip via capillary (40 cm, 50 µm i.d.) by a syringe 
pump (model 402, CMA Microdialysis, North Chelmsford, MA) fitted with 100 µL 
Hamilton syringes (Reno, NV) resulting in a 1:1:1 ratio of solutions.  The inlet flows 
from each of the 3 channels were 250 nL min-1 each resulting in a total volumetric flow 
rate through the device of 750 nL min-1.  The merged streams flowed into a 7.1 cm long 
mixing channel (90 µm width at half-height), which was kept relatively narrow to 
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facilitate mixing, and then a 3.75 cm long incubation channel (648 µm width at half-
height).  The latter channel was wider to reduce the pressure required for pumping.  All 
enzyme assay chip channels were etched to a depth of 60 µm.  The combined lengths 
allowed a 5 min mixing and incubation time.  
 
4. Results and Discussion 
4.1 On-line Enzyme Assay Characterization 
To characterize the response of the system, glycerol standards were pumped 
through the cell perfusion chip and into the enzyme assay chip where they were mixed 
with reagents for the glycerol assay, while monitoring fluorescence (Figure B.2B).  For 
this experiment, glycerol standards were pumped through the perfusion chip at 80 µL 
min-1.  The LOD of the on-line fluorescence-based enzyme assay, determined by the 
concentration that gave a signal 3 times the standard deviation of the blank, was 4 µM for 
glycerol.  The assay gave a linear response from the detection limit to 50 µM glycerol 
(Figure B.2C).  RSDs were from 1-5% indicative of a stable reaction and efficient mixing 
of the reagents.  The signal generated by the fluorescence-based glycerol assay yielded 
similar RSDs over 3 h for both the blank and a 25 µM glycerol standard, typical basal 
concentration of glycerol detected from mature adipocytes, indicating good stability and 
relatively long term operation.  Day-to-day reproducibility of the calibration was good 
with slope equal to 1105 ± 56 RFU µM-1 and intercept 9329 ± 1658 RFU (n = 6). 
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Figure B.2. Characterization of on-line fluorescence-based enzyme assay. (a) The scheme of the 
fluorescence-based enzyme assay for glycerol employed for on-chip mixing and detection is depicted.  
Glycerol kinase (GK), glycerol phosphate oxidase (GPO), peroxidase (HRP), and Amplex UltraRed were 
mixed on-chip with glycerol (either from standards or cell effluent) to form the fluorescent product 
resorufin.  (b) An example step-change calibration utilizing the dual-chip system is shown.  Glycerol 
concentrations ranging between 0-100 µM were perfused through the system to determine the 
corresponding changes in fluorescence. (c) The overall calibration generated a LOD of 4 µM and was linear 
from 0-50 µM glycerol. 
 
The rise time of the system, as determined by a 10-90% change in signal for a 
step-change in glycerol concentration, was 90 s.  If the cell perfusion chip was by-passed, 
the rise time improved to 80 s.  Little change in rise time was observed at various points 
along the incubation channel of the enzyme chip.  These observations combined indicate 
that the greatest source of dispersion was due to the fluidic connections such as the 
connection volumes and transfer capillaries, not the incubation time or the cell chip.   
 
4.2 Glycerol Secretion from Adipocytes 
To test the system for monitoring dynamic changes in glycerol release from 
adipocytes, we monitored glycerol secretion during treatment of adipocytes with the β-
adrenergic agonist isoproterenol, which is known to elevate cellular cAMP, activate 
protein kinase A and stimulate lipolysis [27].  For these experiments, cells were loaded 
into the cell chamber and perfused with glucose-HBSS while monitoring the enzyme 
reaction as described above for the standards.  The cells remained adherent during 
transfer and perfusion.  Basal measurements were collected for at least 60 min and 
yielded an average concentration of 28 + 5 µM (SEM, n = 5).  Upon switching to a 
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perfusion fluid containing 20 µM isoproterenol, a transient burst of glycerol secretion of 
approximately 3-fold over basal secretion was detected followed by a sustained release 
that was ~40% over basal levels (see Figure 3 for sample individual traces and averaged 
responses).  The burst in glycerol release rose within the first 2 min of exposure to 
isoproterenol and decreased after ~6 min.  The cell system gave stable responses allowing 
glycerol secretion to be monitored for at least 3.5 h, although most experiments were 
completed in 2 h. 
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Figure B.3. Glycerol secretion data from differentiated adipocytes and response to isoproterenol treatment. 
(a, b) Representative traces of glycerol release from differentiated adipocytes and response upon 20 µM 
isoproterenol treatment are shown. (c) Five glycerol secretion traces were averaged and shown with ± 
SEM.  The SEM above and below the average was plotted to enable visualization of the error between 
measurements.  The bars above traces represent exposure to 20 µM isoproterenol.  The traces were 
shortened to depict only the time surrounding the initial exposure to isoproterenol. 
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Figure B.4. Control secretion data. (a) Glycerol secretion data was obtained from 95% confluent 
preadipocytes. The bar indicates perfusion of 20 µM isoproterenol.  The y-axis of the insert is 10x greater 
to enable visualization of the glycerol release measured.  (b) The effect of isoproterenol introduction on the 
on-line enzyme assay was determined to be minimal at both 25 µM and 50 µM glycerol. The light grey line 
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indicates perfusion of 0 µM glycerol standard, medium grey 25 µM, and black 50 µM, respectively.  The 
dashed line represents exposure to 20 µM isoproterenol.  (c) The response of the system without the 
enzyme reagent present and upon inclusion of the enzyme reagent during a cellular secretion experiment 
was tested.  The black and grey lines represent the absence and presence of the enzyme reagent, 
respectively.  The dashed line represents treatment with 20 µM isoproterenol.  The y-axis scale of the insert 
is 8x greater for visualization of the release monitored when isoproterenol was introduced in the absence of 
the enzyme reagent. 
 
In several experiments, fractions were collected from the waste capillary and 
analyzed for glycerol using the standard assay yielded glycerol concentrations.  These 
experiments yielded glycerol concentrations that on average were with 6% of the on-line 
measurement (n = 10 fractions from 4 experiments).  Moreover, Getty-Kaushik and 
colleagues reported an increase in overall glycerol secretion upon perfusion of primary 
rat adipocytes with isoproterenol [17].  These results indicate the reliability of the on-line 
measurements.  
 
4.3 Characterization of Cell Perfusion Chip 
We also characterized the perfusion chip with simulations and experiments to 
determine the shear stress on cells and uniformity of drug application to the cells.  Due to 
the fragility of adipocytes, the perfusion chip was designed to have a recessed cell 
chamber area relative to the inlet and outlet flow stream to reduce shear stress and permit 
laminar flow of fluid over the cells.  This design was inspired by previous work that 
showed that shear force is diminished by placing the fluid inlet above the cells and not 
inline with them [28].  The COMSOL model of our chip estimated the shear stress upon 
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the cells at 0.006 N m-2.  This value is in the same range as reported in other microfluidic 
systems employing cell perfusion [5] despite the high volumetric flow rate employed.  
This low value, plus the observation that the flow did not cause cells to detach or deform, 
suggests that the chip design prevents excessive shear on the cells.  
A potential concern with this design is that drugs are not uniformly applied to the 
cells.  To test for uniformity of flow across the width of the cell chamber, food dye was 
flowed into the perfusion chip to visualize the flow profile.    Pictures of the flow showed 
that fluid flow was dispersed evenly across the width of the chip, an observation 
confirmed by COMSOL modeling.  This study also confirmed that: 1) the solution stays 
confined to the cell chamber, i.e., it does not leak past the moat, 2) the chip washes out 
rapidly, and 3) flow exhibits the characteristic parabolic profile of laminar flow.  To 
determine if drugs applied would uniformly reach the bottom of the chip, we used a 
COMSOL model because of the difficulty of directly imaging the depth of penetration of 
dyes.  The model predicted that fluid flowed throughout the entire depth of the cell 
chamber region and that substances in the perfusion flow, such as isoproterenol, would 
rapidly reach a uniform concentration throughout the depth of the chip due to a 
combination of flow and diffusion.  Washout of the cell chamber using the model was 
predicted to occur in 55 s, which closely matched the observed washout time of 60 s and 
further validated the efficacy of the model.  
The results show that the dual-chip system is a useful approach to adipocyte 
culture and monitoring.  Although an integrated chip would likely result in a better 
temporal response by reducing the connection volume between the cells and assay, the 
dual chip platform allowed both components of the system, cell perfusion and enzyme 
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assay, to be optimized separately.  The two-chip approach also had other practical 
advantages including: 1) ability to operate the perfusion chip while inverted if necessary 
to prevent cells floating in the direct flow stream without affecting detection in the assay 
chip (floating cells being a more likely problem with primary adipocytes), and 2) 
compatibility of a reversibly sealed chip, useful for cell loading, and a bonded chip, 
useful for enzyme assay.   
The perfusion chip was designed to overcome challenges associated with coupling 
adipocytes with microfluidic devices.  Glass was chosen as the material for the 
microfluidic chips as adipocytes secrete hydrophobic moieties that may interact with or 
adhere to polymeric materials.  The inline weir at the inlet and exit of the chip (Fig. 1B), 
created through multi-step etching, confined the cells to the cell chamber area and 
prevented cells from creating clogs in downstream channels as adipocytes may become 
non-adherent and float.  The inlet and outlet locations also minimized shear stress on the 
cells while allowing drugs to be uniformly and quantitatively applied.  To circumvent the 
long culture time, murine 3T3-L1 adipocytes were grown on glass cover slips that could 
be placed into the perfusion chip for experiments.  Growing cells on cover slips had 
numerous advantages including: 1) enabling growth of the cells in Petri dishes according 
to previously optimized culture conditions, 2) increased throughput for secretion 
experiments relative to growing cells directly in the cell chamber, 3) decreased variability 
of measurements as multiple cover slips could be tested from the same Petri dish of cells, 
and 4) potential to return cells to culture following an experiment for re-use.  
Furthermore, testing cultured cells in a resealable chip enabled the same device to be 
used numerous times.  Indeed, the same chips were used for the entirety of the 
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experiments presented in this paper (data collected over the course of 6 months).  The 
robustness of the chip increases the convenience of use and negates the cost disadvantage 
of working with glass as the chip material.  
Coupling the perfusion chip with the on-line enzyme assay proved efficacious for 
monitoring cellular activity.  Transient secretion dynamics from adipocytes were able to 
be observed upon treatment with isoproterenol.  The sharp rise in glycerol release within 
the first two minutes of exposure to isoproterenol likely reflects the fast signaling 
associated with phosphorylation and activation of hormone sensitive lipase and other 
proteins involved in lipolysis.  The decrease in secreted levels after ~6 min may be due to 
internalization of the β-adrenergic receptor and pathway desensitization upon continuous 
perfusion of ligand.  Previous work with primary rat adipocytes also has shown a burst in 
glycerol secretion in response to isoproterenol treatment as well as sustained, elevated 
release [17].  The duration of the pulse was ~3 times longer with primary rat adipocytes 
compared to the pulse detected in this work using immortalized 3T3-L1 adipocytes.  
However, a similar increase in overall glycerol levels upon treatment with isoproterenol 
was reported.  In this work, the secretion data also consistently showed two peaks during 
this initial burst of glycerol release.  This effect needs further study but may reflect 
internal dynamics such as mobilization of triacylglycerol stores. 
While adipocyte secretions have previously been monitored off-line fraction 
collection [16-19], this microfluidic-based platform facilitates automated mixing and 
detection to greatly save on labor and reagent costs.  Compared to the same experiments 
performed using off-line assays, i.e. following the manufacturer’s instructions and using 
an equivalent concentration of fluorogenic dye with readout on a plate reader, the chip 
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system employing the on-line enzyme assay consumed less than 1% Amplex UltraRed 
and less than 0.05% enzyme reagent (i.e., 800 µL per aliquot of enzyme reagent is 
consumed off-line with effluent fractions collected every min compared to 250 nL min-1 
on-line).  Additionally, the on-line format diminished labor by removing numerous 
pipetting steps resulting in shorter analysis time.  This work also complements other 
work, such as use of calorimetry for monitoring adipocyte function on chips [29].  The 
fluorescence assay offers specific chemical detection while the calorimetry method offers 
an overview of cell metabolism.   
 
5. Conclusions 
We developed a microfluidic platform consisting of two separate chips to 
integrate cell perfusion, sample handling, and reagent mixing as well as to enable near 
real-time monitoring of glycerol release from cultured adipocytes.  The microfluidic 
platform was able to detect changes in glycerol levels from ~50,000 adipocytes under 
basal conditions and upon pharmacological treatment with isoproterenol.  The use of a 
microfluidic device for on-line mixing and detection reduced the consumption of costly 
reagents to less than 1% of off-line volumes and decreased labor by automating the 
mixing and detection on-chip.  Culturing adipocytes on cover slips increased the 
throughput of cells available for study as well as decreased biological variability as 
multiple experiments could be tested from cells cultured in the original Petri dish.  This 
device may be applied to studying the oscillatory nature of glycerol release and long-term 
changes in metabolism.  While the device has been employed to monitor glycerol 
secretion from 3T3-L1 adipocytes, it is possible that it can be configured to detect other 
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moieties secreted by adipocytes such as non-esterified fatty acids, to test primary 
adipocytes that have been genetically modified and/or exposed to pharmacological 
treatment, or to monitor secretions from other adherent cell types such as osteoblasts. 
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